# EDGAR Filing Document

**Accession Number:** 0002025968
**File Stem:** 0000030146-26-000005
**Filing Date:** 2026-1
**Character Count:** 176298
**Document Hash:** 79c1f24748af8e41d83c15e16c10bed5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000030146-26-000005.hdr.sgml**: 20260102

**ACCESSION NUMBER**: 0000030146-26-000005

**CONFORMED SUBMISSION TYPE**: N-CSR

**PUBLIC DOCUMENT COUNT**: 33

**CONFORMED PERIOD OF REPORT**: 20251031

**FILED AS OF DATE**: 20260102

**DATE AS OF CHANGE**: 20260102

**EFFECTIVENESS DATE**: 20260102

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon ETF Trust II
- **CENTRAL INDEX KEY:** 0002025968

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA

**FILING VALUES:**
- **FORM TYPE:** N-CSR
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23977
- **FILM NUMBER:** 26501165

**BUSINESS ADDRESS:**
- **STREET 1:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

## Series and Classes Contracts Data

### BNY Mellon Concentrated Growth ETF (Series ID: S000087737)

| Class ID   | Class Name                         | Ticker Symbol   |
|:---|:---|:---|
| C000253638 | BNY Mellon Concentrated Growth ETF | BKCG            |

### BNY Mellon Dynamic Value ETF (Series ID: S000087738)

| Class ID   | Class Name                   | Ticker Symbol   |
|:---|:---|:---|
| C000253639 | BNY Mellon Dynamic Value ETF | BKDV            |

?xml version='1.0' encoding='ASCII'? f9dd2622-f127-4213-a6a7-642e566f5393

#### UNITED STATES

#### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

#### FORM N-CSR

------

#### CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES

#### Investment Company Act file number

#### 811-23977

#### BNY Mellon ETF Trust II
(Exact name of registrant as specified in charter)

------

240 Greenwich Street

New York, New York 10286

(Address of Principal Executive Officer) (Zip Code)

Deirdre Cunnane, Esq.

240 Greenwich Street

New York, New York 10286

(Name and Address of Agent for Service)

#### Registrant's telephone number, including area code:
&nbsp;&nbsp;&nbsp;&nbsp;(212) 922-6400

#### Date of fiscal year end:

#### 10/31

#### Date of reporting period:

#### 10/31/25
The following N-CSR relates only to the Registrant's series listed below and does not relate to any series of the Registrant with a different fiscal year end and, therefore, different N-CSR reporting requirements. A separate N-CSR will be filed for any series with a different fiscal year end, as appropriate.

BNY Mellon Concentrated Growth ETF

BNY Mellon Dynamic Value ETF

ITEM 1 - Reports to Stockholders

BNY Mellon Dynamic Value ETF

#### ANNUAL SHAREHOLDER REPORT

#### October 31, 2025

#### Ticker – BKDV (NYSE Arca, Inc.)
This annual shareholder report contains important information about BNY Mellon Dynamic Value ETF (the "Fund") for the period of November 4, 2024 (commencement of operations) to October 31, 2025. You can find additional information about the Fund at bny.com/investments/etfliterature. You can also request this information by calling 1-833-383-2696 or calling your financial adviser.

#### What were the Fund's costs for the last period ?
(based on a hypothetical $10,000 investment)

---

| | | |
|:---|:---|:---|
| **Fund** | **Costs of a $10,000 investment** | **Costs paid as a percentage of a $10,000 investment** |
| BNY Mellon Dynamic Value ETF | $63 | 0.60%\* |

---

\* Annualized.

#### How did the Fund perform last period ?
* For the period November 1, 2024 (the Fund's inception) through October 31, 2025, the Fund's shares returned 12.20% on a net asset value basis and 12.31% on a market price basis.

* In comparison, the Russell 1000<sup>®</sup> Value Index (the "Index") returned 11.15% for the same period.

**What affected the Fund's performance?**

* U.S. markets advanced during the reporting period, supported by strong corporate earnings and increased capital expenditures spending, as well as Artificial Intelligence (AI) exuberance and expectations for easing monetary policy.

* Strong stock selection in energy, materials and financials bolstered the Fund's performance relative to the Index.

* Stock selection in health care and communication services, including lack of exposure to the leading AI names, detracted from the Fund's relative returns.

#### How did the Fund perform since its inception?
**The Fund's past performance is not a good predictor of the Fund's future performance.** The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.

**Cumulative Performance from November 1, 2024 through October 31, 2025** 

**Initial Investment of $10,000**

![Fund Performance - Growth of 10K Chart](chartimages_10957296.jpg)

The above graph compares a hypothetical $10,000 investment in the Fund's shares to a hypothetical investment of $10,000 made in each of the Russell 1000<sup>®</sup> Index (a broad-based index) and Russell 1000<sup>®</sup> Value Index on 11/1/2024, the Fund's inception. The performance shown takes into account applicable fees and expenses of the Fund, including management fees and other expenses. The Fund's performance also assumes the reinvestment of dividends and capital gains. Unlike the Fund, the indexes are not subject to fees and other expenses. Investors cannot invest directly in any index.

**AVERAGE ANNUAL TOTAL RETURNS (AS OF 10/31/25)**

---

| | |
|:---|:---|
|  | **SINCE INCEPTION <br>(November 1, 2024)** |
| BNY Mellon Dynamic Value ETF - NAV Return | 12.20% |
| Russell 1000<sup>®</sup> Index (broad-based index) | 21.14% |
| Russell 1000<sup>®</sup> Value Index | 11.15% |

---

**The performance data quoted represent past performance, which is no guarantee of future results. For more current information visit bny.com/investments/etfliterature .**

**KEY FUND STATISTICS (AS OF 10/31/25)**

---

| | | | |
|:---|:---|:---|:---|
| **<br>Fund Size (Millions)** | **<br>Number of Holdings** | **Total Advisory Fee Paid During<br>Period** | **<br>Annual Portfolio Turnover** |
| $559 | 75 | $1442210 | 104.28% |

---

**Portfolio Holdings (as of 10/31/25)**

**Top Ten Holdings (Based on Net Assets) <sup>\*</sup>**![Graphical Representation - Top N Holdings Chart](chartimages_10957307.jpg)

\* Excludes money market funds or other short-term securities held for the investment of cash and cash collateral for securities loaned, if any.

**Sector Allocation (Based on Net Assets)**

![Graphical Representation - Allocation 1 Chart](chartimages_10957314.jpg)

**For additional information about the Fund, including its prospectus, financial information, portfolio holdings and proxy voting information, please visit bny.com/investments/etfliterature .**

 **Not FDIC Insured. Not Bank-Guaranteed. May Lose Value**© 2025 **BNY Mellon Securities Corporation**, Distributor,

240 Greenwich Street, 9th Floor, New York, NY 10286

Code-4866AR1025

![TSR- BNY Investment Logo](images_30017.jpg)

BNY Mellon Concentrated Growth ETF

#### ANNUAL SHAREHOLDER REPORT

#### October 31, 2025

#### Ticker – BKCG (NYSE Arca, Inc.)
This annual shareholder report contains important information about BNY Mellon Concentrated Growth ETF (the "Fund") for the period of November 1, 2024 to October 31, 2025. You can find additional information about the Fund at bny.com/investments/etfliterature. You can also request this information by calling 1-833-383-2696 or calling your financial adviser.

**This report describes changes to the Fund that occurred during the reporting period.**

#### What were the Fund's costs for the last year ?
(based on a hypothetical $10,000 investment)

---

| | | |
|:---|:---|:---|
| **Fund** | **Costs of a $10,000 investment** | **Costs paid as a percentage of a $10,000 investment** |
| BNY Mellon Concentrated Growth ETF<sup>\*</sup> | $71 | 0.66% |

---

\* During the period, fees were waived and/or expenses reimbursed pursuant to an agreement with the Fund's investment adviser, BNY Mellon Investment Adviser, Inc. If this agreement is not extended in the future, expenses could be higher.

#### How did the Fund perform last year ?
* For the 12-month period ended October 31, 2025, the Fund's shares returned 15.21% on a net asset value basis and 15.30% on a market price basis.

* In comparison, the S&P 500<sup>®</sup> Index (the "Index") returned 21.45% for the same period.

**What affected the Fund's performance?**

* U.S. stocks advanced during the reporting period, supported by investor enthusiasm for AI-related investment announcements, tariff negotiations, accommodative central bank policies and strong corporate earnings growth.

* The strongest contributors to the Fund's performance relative to the Index included allocation effects in real estate, consumer staples and energy, as well as stock selection in real estate.

* Relative performance of the Fund suffered as negative stock selection outweighed a positive allocation effect in information technology. Both allocation and stock selection effects detracted from relative Fund returns in health care and financials.

#### How did the Fund perform over the past 10 years?
**The Fund's past performance is not a good predictor of the Fund's future performance.** The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.

**Cumulative Performance from November 1 , 2015 through October 31, 2025** 

**Initial Investment of $10,000**

![Fund Performance - Growth of 10K Chart](chartimages_10957246.jpg)

The above graph compares a hypothetical $10,000 investment in the Fund's shares to a hypothetical investment of $10,000 made in the S&P 500<sup>®</sup> Index on 10/31/2015. The performance shown takes into account applicable fees and expenses of the Fund, including management fees and other expenses. The Fund's performance also assumes the reinvestment of dividends and capital gains. Unlike the Fund, the Index is not subject to fees and other expenses. Investors cannot invest directly in any index.

**AVERAGE ANNUAL TOTAL RETURNS (AS OF 10/31/25)**

---

| | | | |
|:---|:---|:---|:---|
|  | **1YR** | **5YR** | **10YR** |
| BNY Mellon Concentrated Growth ETF - NAV Return | 15.21% | 12.89% | 12.62% |
| S&P 500<sup>®</sup> Index | 21.45% | 17.64% | 14.63% |

---

Periods prior to the inception date of the Fund's ETF shares (3/28/2025) reflect the performance of BNY Mellon Tax Managed Growth Fund's Class I shares. Such performance figures have not been adjusted to reflect applicable fees and expenses of the Fund's ETF shares.

**The performance data quoted represent past performance, which is no guarantee of future results. For more current information visit bny.com/investments/etfliterature .**

**KEY FUND STATISTICS (AS OF 10/31/25)**

---

| | | | |
|:---|:---|:---|:---|
| **<br>Fund Size (Millions)** | **<br>Number of Holdings** | **Total Advisory Fee Paid During<br>Period** | **<br>Annual Portfolio Turnover** |
| $123 | 27 | $810925 | 14.05% |

---

**Portfolio Holdings (as of 10/31/25)**

**Top Ten Holdings (Based on Net Assets) <sup>\*</sup>**![Graphical Representation - Top N Holdings Chart](chartimages_10957257.jpg)

\* Excludes money market funds or other short-term securities held for the investment of cash and cash collateral for securities loaned, if any.

**Sector Allocation (Based on Net Assets)**

![Graphical Representation - Allocation 1 Chart](chartimages_10957264.jpg)

\* Amount represents less than .1%.

**How has the Fund changed?**

* On March 28, 2025, BNY Mellon Tax Managed Growth Fund ("Predecessor Fund"), a series of BNY Mellon Investment Funds IV, Inc., was reorganized into the Fund ("Reorganization"). The Fund commenced operations upon completion of the Reorganization and continues the operations of the Predecessor Fund.

#### Changes in or Disagreements with Accountants
* Starting March 28, 2025, in connection with the Reorganization noted above, Ernst & Young LLP ("EY") became the independent registered public accounting firm of the Fund and KPMG LLP was discharged as the Predecessor Fund's accounting firm. EY serves as the independent registered public accounting firm for all funds in the BNY Mellon ETF Trust II. There were no disagreements with the former accounting firm during the Predecessor Fund's fiscal years ended October 31, 2024 and October 31, 2023 and the subsequent interim period through March 28, 2025.

**This is a summary of certain changes to the Fund since November 1, 2024 . For more complete information, you may review the Fund's current prospectus dated March 31, 2025 at bny.com/investments/etfliterature or upon request at 1-833-383-2696 or by calling your financial adviser.**

**For additional information about the Fund, including its prospectus, financial information, portfolio holdings and proxy voting information, please visit bny.com/investments/etfliterature .**

 **Not FDIC Insured. Not Bank-Guaranteed. May Lose Value**© 2025 **BNY Mellon Securities Corporation**, Distributor,

240 Greenwich Street, 9th Floor, New York, NY 10286

Code-4869AR1025

![TSR- BNY Investment Logo](images_30017.jpg)

------

**Item 1. Reports to Stockholders (cont.).**

(b)&nbsp;&nbsp;&nbsp;&nbsp; Not applicable.

**Item 2. Code of Ethics.**

(a) As of the period ended October 31, 2025 (the "Reporting Period"), the Registrant has adopted a
 code of ethics that applies to the Registrant's principal executive officer, principal financial officer, principal accounting officer,
 controller or persons performing similar functions, regardless of whether these individuals are employed by the Registrant or a third
 party.

(c) During the Reporting Period, there have been no amendments to a provision of the code of ethics that applies
 to the Registrant's principal executive officer, principal financial officer, principal accounting officer or controller, or persons
 performing similar functions, regardless of whether these individuals are employed by the Registrant or a third party, and that relates
 to any element of the code of ethics description.

(d) During the Reporting Period, the Registrant has not granted any waivers, including an implicit waiver, from
 a provision of the code of ethics to the Registrant's principal executive officer, principal financial officer, principal accounting
 officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the Registrant
 or a third party, that relates to one or more of the items set forth in paragraph (b) of this item's instructions.

**Item 3. Audit Committee Financial Expert.**

The Registrant's Board of Trustees has determined that Mr. Kevin W. Quinn is qualified to serve as an audit committee financial expert serving on the Registrant's audit committee and that he is "independent," as defined by Item 3 of Form N-CSR.

**Item 4. Principal Accountant Fees and Services.** 

(a)&nbsp;&nbsp;&nbsp;&nbsp; Audit Fees

The aggregate fees billed for the period March 28, 2025 (commencement of operations) through October 31, 2025 for BNY Mellon Concentrated Growth ETF and for the period November 4, 2024 (commencement of operations) through October 31, 2025 for BNY Mellon Dynamic Value ETF for professional services rendered by the principal accountant for the audit of the Registrant's annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements were $40,326.

(b)&nbsp;&nbsp;&nbsp;&nbsp; Audit-Related Fees

The aggregate fees billed for the period March 28, 2025 (commencement of operations) through October 31, 2025 for BNY Mellon Concentrated Growth ETF and for the period November 4, 2024 (commencement of operations) through October 31, 2025 for BNY Mellon Dynamic Value ETF for assurance and related services rendered to the Registrant by the principal accountant that are reasonably related to the performance of the audit of the Registrant's financial statements and are not reported under paragraph (a) of this Item were $12,734. These services consisted of security counts required by Rule 17f-2 under the 1940 Act.

(c)&nbsp;&nbsp;&nbsp;&nbsp; Tax Fees

The aggregate fees billed for the period March 28, 2025 (commencement of operations) through October 31, 2025 for BNY Mellon Concentrated Growth ETF and for the period November 4, 2024 (commencement of operations) through October 31, 2025 for BNY Mellon Dynamic Value ETF for professional services rendered to the Registrant by the principal accountant for tax compliance, tax advice and tax planning were $8,146. These services consisted of (i) review or preparation of U.S. federal, state, local and excise tax returns; (ii) U.S. federal, state and local entity tax planning, advice and assistance regarding statutory, regulatory or administrative developments, and (iii) tax advice regarding tax qualification.

(d)&nbsp;&nbsp;&nbsp;&nbsp; All Other Fees

The aggregate fees billed for the period March 28, 2025 (commencement of operations) through October 31, 2025 for BNY Mellon Concentrated Growth ETF and for the period November 4, 2024 (commencement of operations) through October 31, 2025 for BNY Mellon Dynamic Value ETF for products and services provided by the principal accountant, other than the services reported in paragraphs (a) through (c) of this Item were $0.

---

| | |
|:---|:---|
| (e)(1) | Pursuant to the Registrant's Audit Committee Charter that has been adopted by the audit committee, the audit committee shall approve all audit and permissible non-audit services to be provided to the Registrant and all permissible non-audit services to be provided to its investment adviser or any entity controlling, controlled by or under common control with the investment adviser that provides ongoing services to the Registrant if the engagement relates directly to the operations and financial reporting of the Registrant. |

---

---

| | |
|:---|:---|
| (e)(2) | The percentage of services described in paragraphs (b) through (d) of this Item that were approved by the audit committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X, with respect to: Audit-Related Fees was 100%; Tax Fees was 100%; and All Other Fees was 0%. |

---

(f) The percentage of hours expended on the principal accountant's engagement to audit the Registrant's
 financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant's
 full-time, permanent employees was less than fifty percent.

(g) The aggregate non-audit fees billed by the Registrant's accountant for services rendered to the Registrant,
 and rendered to the Registrant's investment adviser (not including any sub-adviser whose role is primarily portfolio management
 and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control
 with the investment adviser that provides ongoing services to the Registrant for the period March 28, 2025 (commencement of operations)
 through October 31, 2025 for BNY Mellon Concentrated Growth ETF and for the period November 4, 2024 (commencement of operations) through
 October 31, 2025 for BNY Mellon Dynamic Value ETF Registrant were $196,953.

(h) The Registrant's audit committee has considered whether the provision of non-audit services that were
 rendered to the Registrant's investment adviser (not including any sub-adviser whose role is primarily portfolio management and
 is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with
 the investment adviser that provides ongoing services to the Registrant that were not pre-approved pursuant to

paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountant's independence.

(i) Not applicable.

(j) Not applicable.

**Item 5. Audit Committee of Listed Registrants.**

(a) The Registrant has a separately designated audit committee established in accordance with Section 3(a)(58)(A)
 of the Securities Exchange Act of 1934, as amended, which consists of independent trustees of the Registrant. The audit committee members
 are J. Charles Cardona, Kristen M. Dickey, F. Jack Liebau, Jr., Jill I. Mavro, Kevin W. Quinn, and Stacy L. Schaus.

(b)&nbsp;&nbsp;&nbsp;&nbsp; Not applicable.

**Item 6. Investments.**

(a) The Schedule of Investments in securities of unaffiliated issuers as of the close of the Reporting Period
 is included in the financial statements filed under Item 7 of this Form N-CSR.

(b)&nbsp;&nbsp;&nbsp;&nbsp; Not applicable.

**Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.**

The following is a copy of the Registrant's most recent financial statements and financial highlights.

**BNY Mellon ETF Trust II**

**ANNUAL FINANCIALS AND OTHER INFORMATION**

October 31, 2025

------

**BNY Mellon Concentrated Growth ETF:** BKCG

Principal U.S. Listing Exchange: NYSE Arca, Inc.

![](img3d497e391.gif)

------

**Save time. Save paper. View your next shareholder report online as soon as it's available. Log into** www.bny.com/investments **and sign up for eCommunications. It's simple and only takes a few minutes.**

------

The views expressed herein are current to the date of this report. These views and the composition of the

fund's portfolio is subject to change at any time based on market and other conditions.

Not FDIC-Insured • Not Bank-Guaranteed • May Lose Value

------

Contents

The Fund

Please note the Annual Financials and Other Information only contains Items 7-11 required in Form N-CSR. All other required items will be filed with the Securities and Exchange Commission (the "SEC").

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| **[Item 7. Financial Statements and Financial Highlights for Open-End Management](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_SOI-Commoncontent-5108_1)**<br> **[Investment Companies](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_SOI-Commoncontent-5108_1)**<br>| 3 |
| [Schedule of Investments](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_SOI-Commoncontent-5108_1) | 3 |
| [Statement of Assets and Liabilities](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_FS-Commoncontent-5108_1) | 5 |
| [Statement of Operations](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_FS-Commoncontent-5108_2) | 6 |
| [Statement of Changes in Net Assets](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_FS-Commoncontent-5108_3) | 7 |
| [Financial Highlights](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_FIHI-Commoncontent-5108_1) | 9 |
| [Notes to Financial Statements](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_NTF-Commoncontent-5108_1) | 10 |
| [Report of Independent Registered Public Accounting Firm](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_AUD-Commoncontent-5108_1) | 17 |
| [Important Tax Information](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_ITI-Commoncontent-5108_1) | 18 |
| **[Item 8. Changes in and Disagreements with Accountants for Open-End Management](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_CDA-Commoncontent-5108_1)**<br> **[Investment Companies](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_CDA-Commoncontent-5108_1)**<br>| 19 |
| **[Item 9. Proxy Disclosures for Open-End Management Investment Companies](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_PRXD-Commoncontent-5108_1)** | 20 |
| **[Item 10. Remuneration Paid to Directors, Officers, and Other of Open-End](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_RMNP-Commoncontent-5108_1)**<br> **[Management Investment Companies](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_RMNP-Commoncontent-5108_1)**<br>| 21 |
| **[Item 11. Statement Regarding Basis for Approval of Investment Advisory Contracts](#xx_141aa19a-bafd-4160-9c78-16116a0bf65e_AAA-Commoncontent-5108_1)** | 22 |

---

------

Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.

BNY Mellon Concentrated Growth ETF

SCHEDULE OF INVESTMENTS

October 31, 2025

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 96.4%** | **Common Stocks — 96.4%** | **Common Stocks — 96.4%** |
| **Capital Goods — 7.9%** | **Capital Goods — 7.9%** | **Capital Goods — 7.9%** |
| BAE Systems PLC, ADR | 36195 | 3580048 |
| Deere & Co. | 5126 | 2366315 |
| Eaton Corp. PLC | 9693 | 3698461 |
|  |  | **9644824** |
| **Consumer Discretionary Distribution & Retail — 10.3%** | **Consumer Discretionary Distribution & Retail — 10.3%** | **Consumer Discretionary Distribution & Retail — 10.3%** |
| Amazon.com, Inc.<sup>(a)</sup> <br>| 38767 | 9467677 |
| The Home Depot, Inc. | 8290 | 3146801 |
|  |  | **12614478** |
| **Consumer Durables & Apparel — 1.2%** | **Consumer Durables & Apparel — 1.2%** | **Consumer Durables & Apparel — 1.2%** |
| LVMH Moet Hennessy Louis Vuitton SE, ADR | 10355 | **1464301** |
| **Financial Services — 14.6%** | **Financial Services — 14.6%** | **Financial Services — 14.6%** |
| Blackrock, Inc. | 3702 | 4008563 |
| Intercontinental Exchange, Inc. | 18006 | 2634098 |
| Mastercard, Inc., Cl. A | 9256 | 5109219 |
| S&P Global, Inc. | 4296 | 2093054 |
| Visa, Inc., Cl. A | 11908 | 4057532 |
|  |  | **17902466** |
| **Food, Beverage & Tobacco — 2.6%** | **Food, Beverage & Tobacco — 2.6%** | **Food, Beverage & Tobacco — 2.6%** |
| Philip Morris International, Inc. | 21747 | **3138744** |
| **Health Care Equipment & Services — 3.6%** | **Health Care Equipment & Services — 3.6%** | **Health Care Equipment & Services — 3.6%** |
| Intuitive Surgical, Inc.<sup>(a)</sup> <br>| 8224 | **4393919** |
| **Insurance — 2.1%** | **Insurance — 2.1%** | **Insurance — 2.1%** |
| The Progressive Corp. | 12845 | **2646070** |
| **Media & Entertainment — 10.7%** | **Media & Entertainment — 10.7%** | **Media & Entertainment — 10.7%** |
| Alphabet, Inc., Cl. C | 28118 | 7924215 |
| Meta Platforms, Inc., Cl. A | 8132 | 5272382 |
|  |  | **13196597** |
| **Pharmaceuticals, Biotechnology & Life Sciences — 5.4%** | **Pharmaceuticals, Biotechnology & Life Sciences — 5.4%** | **Pharmaceuticals, Biotechnology & Life Sciences — 5.4%** |
| AstraZeneca PLC, ADR | 29811 | 2456426 |
| Eli Lilly & Co. | 4808 | 4148631 |
|  |  | **6605057** |
| **Semiconductors & Semiconductor Equipment — 19.6%** | **Semiconductors & Semiconductor Equipment — 19.6%** | **Semiconductors & Semiconductor Equipment — 19.6%** |
| ASML Holding NV | 5477 | 5801403 |
| NVIDIA Corp. | 62783 | 12712930 |
| Taiwan Semiconductor Manufacturing Co. Ltd., ADR | 10671 | 3205888 |
| Texas Instruments, Inc. | 14296 | 2308232 |
|  |  | **24028453** |
| **Software & Services — 13.6%** | **Software & Services — 13.6%** | **Software & Services — 13.6%** |
| Intuit, Inc. | 6879 | 4592077 |
| Microsoft Corp. | 17846 | 9240837 |
| ServiceNow, Inc.<sup>(a)</sup> <br>| 3062 | 2814835 |
|  |  | **16647749** |
| **Technology Hardware & Equipment — 4.8%** | **Technology Hardware & Equipment — 4.8%** | **Technology Hardware & Equipment — 4.8%** |
| Apple, Inc. | 21850 | **5907584** |
| **Total Common Stocks** <br>(cost $57,728,154)<br>|  | **118190242** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**3**

------

SCHEDULE OF INVESTMENTS (continued)

------

---

| | | | |
|:---|:---|:---|:---|
| Description | 1-Day <br>Yield (%)<br>| Shares | Value ($) |
| **Investment Companies — 3.6%** | **Investment Companies — 3.6%** | **Investment Companies — 3.6%** | **Investment Companies — 3.6%** |
| **Registered Investment Companies — 3.6%** | **Registered Investment Companies — 3.6%** | **Registered Investment Companies — 3.6%** | **Registered Investment Companies — 3.6%** |
| Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares<sup>(b)</sup> <br>(cost $4,442,801)<br>| 4.04 | 4442801 | **4442801** |
| **Total Investments** (cost $62,170,955) | **Total Investments** (cost $62,170,955) | **100.0%** | **122633043** |
| **Cash and Receivables (Net)** | **Cash and Receivables (Net)** | **.0%** | **52972** |
| **Net Assets**  | **Net Assets**  | **100.0%** | **122686015** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

ADR—American Depositary Receipt<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> Non-income producing security. <br> <sup>(b)</sup> Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's prospectus.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Affiliated Issuers** | **Affiliated Issuers** | **Affiliated Issuers** | **Affiliated Issuers** | **Affiliated Issuers** | **Affiliated Issuers** |
| Description | Value ($) <br>10/31/2024<br>| Purchases ($)<sup>†</sup> <br>| Sales ($) | Value ($) <br>10/31/2025<br>| Dividends/ <br>Distributions ($)<br>|
| **Registered Investment Companies - 3.6%**<sup>††</sup> | **Registered Investment Companies - 3.6%**<sup>††</sup> | **Registered Investment Companies - 3.6%**<sup>††</sup> | **Registered Investment Companies - 3.6%**<sup>††</sup> | **Registered Investment Companies - 3.6%**<sup>††</sup> | **Registered Investment Companies - 3.6%**<sup>††</sup> |
| Dreyfus Institutional Preferred Government Money Market <br> Fund, Institutional Shares - 3.6%<br>| - | 6944411 | (2501610) | 4442801 | 55771 |
| Dreyfus Institutional Preferred Government Plus Money <br> Market Fund, Institutional Shares - .0%<br>| 1059523 | 9861843 | (10921366) | - | 14278 |
| **Investment of Cash Collateral for Securities Loaned - .0%**<sup>††</sup> | **Investment of Cash Collateral for Securities Loaned - .0%**<sup>††</sup> | **Investment of Cash Collateral for Securities Loaned - .0%**<sup>††</sup> | **Investment of Cash Collateral for Securities Loaned - .0%**<sup>††</sup> | **Investment of Cash Collateral for Securities Loaned - .0%**<sup>††</sup> | **Investment of Cash Collateral for Securities Loaned - .0%**<sup>††</sup> |
| Dreyfus Institutional Preferred Government Plus Money <br> Market Fund, Institutional Shares - .0%<br>| 1210985 | 7667204 | (8878189) | - | 1075<sup>†††</sup> <br>|
| Dreyfus Institutional Preferred Government Money Market <br> Fund, Institutional Shares - .0%<br>| - | 17528106 | (17528106) | - | 8273<sup>†††</sup> <br>|
| **Total - 3.6%** | **2270508** | **42001564** | **(39829271)** | **4442801** | **79397** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| <sup>†</sup> <br>| Includes reinvested dividends/distributions. |
| <sup>††</sup> <br>| Effective March 28, 2025, due to the fund converting to an ETF, the cash vehicle and the cash collateral for securities lending was transferred from Dreyfus <br> Institutional Preferred Government Plus Money Market Fund, Institutional Shares to Dreyfus Institutional Preferred Government Money Market Fund, <br> Institutional Shares.<br>|
| <sup>†††</sup> <br>| Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and <br> other payments to and from borrowers of securities.<br>|

---

See notes to financial statements.

**4**

------

STATEMENT OF ASSETS AND LIABILITIES

October 31, 2025

---

| | | |
|:---|:---|:---|
|  | Cost | Value |
| **Assets ($):** |  |  |
| Investments in securities—See Schedule of Investments: |  |  |
| Unaffiliated issuers | 57728154 | &nbsp;&nbsp;&nbsp;&nbsp; 118190242 |
| Affiliated issuers | 4442801 | &nbsp;&nbsp;&nbsp;&nbsp; 4442801 |
| Dividends and securities lending income receivable |  | &nbsp;&nbsp;&nbsp;&nbsp; 77538 |
| Tax reclaim receivable—Note 2(b)  |  | &nbsp;&nbsp;&nbsp;&nbsp; 52733 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; **122763314** |
| **Liabilities ($):** |  |  |
| Due to BNY Mellon ETF Investment Adviser, LLC—Note 4(b)  |  | &nbsp;&nbsp;&nbsp;&nbsp; 51800 |
| Payable for shares of Beneficial Interest redeemed |  | &nbsp;&nbsp;&nbsp;&nbsp; 25499 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; **77299** |
| **Net Assets ($)** |  | &nbsp;&nbsp;&nbsp;&nbsp; **122686015** |
| **Composition of Net Assets ($):** |  |  |
| Paid-in capital |  | &nbsp;&nbsp;&nbsp;&nbsp; 62163520 |
| Total distributable earnings (loss) |  | &nbsp;&nbsp;&nbsp;&nbsp; 60522495 |
| **Net Assets ($)** |  | &nbsp;&nbsp;&nbsp;&nbsp; **122686015** |
| **Shares Outstanding** |  |  |
| Shares outstanding no par value (unlimited shares authorized) |  | &nbsp;&nbsp;&nbsp;&nbsp; 3385885 |
| **Net Asset Value Per Share ($)** |  | &nbsp;&nbsp;&nbsp;&nbsp;**36.23** |
| **Market Price Per Share ($)** |  | &nbsp;&nbsp;&nbsp;&nbsp;**36.26** |

---

See notes to financial statements.

**5**

------

STATEMENT OF OPERATIONS

Year Ended October 31, 2025<sup>(a)</sup>

---

| | |
|:---|:---|
| **Investment Income ($):** |  |
| **Income:** |  |
| Cash dividends (net of $30,197 foreign taxes withheld at source): |  |
| Unaffiliated issuers | &nbsp;&nbsp;&nbsp;&nbsp; 1317606 |
| Affiliated issuers | &nbsp;&nbsp;&nbsp;&nbsp; 70049 |
| Affiliated income net of rebates from securities lending—Note 2(c)  | &nbsp;&nbsp;&nbsp;&nbsp; 9348 |
| Interest | &nbsp;&nbsp;&nbsp;&nbsp; 1984 |
| **Total Income** | &nbsp;&nbsp;&nbsp;&nbsp; **1398987** |
| **Expenses:** |  |
| Management fee—Note 4(a)  | &nbsp;&nbsp;&nbsp;&nbsp; 873073 |
| Distribution/Service Plans fees—Note 4(b)  | &nbsp;&nbsp;&nbsp;&nbsp; 108307 |
| Directors' fees—Notes 4(a) and 4(c)  | &nbsp;&nbsp;&nbsp;&nbsp; 7055 |
| Loan commitment fees—Note 3  | &nbsp;&nbsp;&nbsp;&nbsp; 655 |
| **Total Expenses** | &nbsp;&nbsp;&nbsp;&nbsp; **989090** |
| Less—reduction in expenses due to undertaking—Note 4(a)  | &nbsp;&nbsp;&nbsp;&nbsp; (55093)<br>|
| Less—Directors' fees reimbursed by <br>BNY Mellon Investment Adviser, Inc.—Note 4(a) <br>| &nbsp;&nbsp;&nbsp;&nbsp; (7055)<br>|
| Less—reduction in Distribution Plan fees—Note 4(a)  | &nbsp;&nbsp;&nbsp;&nbsp; (105637)<br>|
| **Net Expenses** | &nbsp;&nbsp;&nbsp;&nbsp; **821305** |
| **Net Investment Income** | &nbsp;&nbsp;&nbsp;&nbsp; **577682** |
| **Realized and Unrealized Gain (Loss) on Investments—Note 5 ($):** |  |
| Net realized gain (loss) on investments and foreign currency transactions | &nbsp;&nbsp;&nbsp;&nbsp; 16676912 |
| Net realized gain (loss) on in-kind redemptions | &nbsp;&nbsp;&nbsp;&nbsp; 27248510 |
| **Net Realized Gain (Loss)** | &nbsp;&nbsp;&nbsp;&nbsp; **43925422** |
| Net change in unrealized appreciation (depreciation) on investments and foreign currency transactions | &nbsp;&nbsp;&nbsp;&nbsp; (26127125)<br>|
| **Net Realized and Unrealized Gain (Loss) on Investments** | &nbsp;&nbsp;&nbsp;&nbsp; **17798297** |
| **Net Increase in Net Assets Resulting from Operations** | &nbsp;&nbsp;&nbsp;&nbsp; **18375979** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> After the close of business on March 28, 2025, BNY Mellon Tax Managed Growth Fund (the "Predecessor Fund") was reorganized into BNY Mellon Concentrated Growth ETF. The amounts disclosed include those of the Predecessor Fund. See Note 1 for additional information on the reorganization. 

See notes to financial statements.

**6**

------

STATEMENT OF CHANGES IN NET ASSETS

---

| | | |
|:---|:---|:---|
|  | Year Ended October 31, | Year Ended October 31, |
|  | 2025<sup>(a),(b),(c)</sup> <br>| 2024<sup>(a)</sup> <br>|
| **Operations ($):** |  |  |
| Net investment income | &nbsp;&nbsp;&nbsp;&nbsp; 577682 | &nbsp;&nbsp;&nbsp;&nbsp; 363072 |
| Net realized gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp; 43925422 | &nbsp;&nbsp;&nbsp;&nbsp; 18777927 |
| Net change in unrealized appreciation (depreciation) on investments | &nbsp;&nbsp;&nbsp;&nbsp; (26127125) | &nbsp;&nbsp;&nbsp;&nbsp; 9521872 |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | &nbsp;&nbsp;&nbsp;&nbsp; **18375979** | &nbsp;&nbsp;&nbsp;&nbsp; **28662871** |
| **Distributions ($):** |  |  |
| Distributions to shareholders: |  |  |
| ETF shares | &nbsp;&nbsp;&nbsp;&nbsp; (507021) | &nbsp;&nbsp;&nbsp;&nbsp; - |
| Class A | &nbsp;&nbsp;&nbsp;&nbsp; (26913854) | &nbsp;&nbsp;&nbsp;&nbsp; (6824327) |
| Class C | &nbsp;&nbsp;&nbsp;&nbsp; (786825) | &nbsp;&nbsp;&nbsp;&nbsp; (225471) |
| Class I | &nbsp;&nbsp;&nbsp;&nbsp; (7152860) | &nbsp;&nbsp;&nbsp;&nbsp; (1981880) |
| **Total Distributions** | &nbsp;&nbsp;&nbsp;&nbsp; **(35360560)** | &nbsp;&nbsp;&nbsp;&nbsp; **(9031678)** |
| **Beneficial Interest Transactions ($):** |  |  |
| Net proceeds from shares sold: |  |  |
| ETF shares | &nbsp;&nbsp;&nbsp;&nbsp; 33691846 | &nbsp;&nbsp;&nbsp;&nbsp; - |
| Class A | &nbsp;&nbsp;&nbsp;&nbsp; 3198933 | &nbsp;&nbsp;&nbsp;&nbsp; 1476112 |
| Class C | &nbsp;&nbsp;&nbsp;&nbsp; 250 | &nbsp;&nbsp;&nbsp;&nbsp; 294448 |
| Class I | &nbsp;&nbsp;&nbsp;&nbsp; 90944324 | &nbsp;&nbsp;&nbsp;&nbsp; 1986252 |
| Net assets received in connection with reorganization—Note 1 | &nbsp;&nbsp;&nbsp;&nbsp; 111903401 | &nbsp;&nbsp;&nbsp;&nbsp; - |
| Distributions reinvested: |  |  |
| Class A | &nbsp;&nbsp;&nbsp;&nbsp; 23036046 | &nbsp;&nbsp;&nbsp;&nbsp; 5851618 |
| Class C | &nbsp;&nbsp;&nbsp;&nbsp; 784813 | &nbsp;&nbsp;&nbsp;&nbsp; 225471 |
| Class I | &nbsp;&nbsp;&nbsp;&nbsp; 6982587 | &nbsp;&nbsp;&nbsp;&nbsp; 1920003 |
| Cost of shares redeemed: |  |  |
| ETF shares | &nbsp;&nbsp;&nbsp;&nbsp; (43641405) | &nbsp;&nbsp;&nbsp;&nbsp; - |
| Class A | &nbsp;&nbsp;&nbsp;&nbsp; (105892570) | &nbsp;&nbsp;&nbsp;&nbsp; (8155093) |
| Class C | &nbsp;&nbsp;&nbsp;&nbsp; (3002057) | &nbsp;&nbsp;&nbsp;&nbsp; (790024) |
| Class I | &nbsp;&nbsp;&nbsp;&nbsp; (119105712) | &nbsp;&nbsp;&nbsp;&nbsp; (5672035) |
| **Increase (Decrease) in Net Assets from Beneficial Interest Transactions** | &nbsp;&nbsp;&nbsp;&nbsp; **(1099544)** | &nbsp;&nbsp;&nbsp;&nbsp; **(2863248)** |
| **Total Increase (Decrease) in Net Assets** | &nbsp;&nbsp;&nbsp;&nbsp; **(18084125)** | &nbsp;&nbsp;&nbsp;&nbsp; **16767945** |
| **Net Assets ($):** |  |  |
| Beginning of Period | &nbsp;&nbsp;&nbsp;&nbsp; 140770140 | &nbsp;&nbsp;&nbsp;&nbsp; 124002195 |
| **End of Period** | &nbsp;&nbsp;&nbsp;&nbsp; **122686015** | &nbsp;&nbsp;&nbsp;&nbsp; **140770140** |

---

**7**

------

STATEMENT OF CHANGES IN NET ASSETS (continued)

---

| | | |
|:---|:---|:---|
|  | Year Ended October 31, | Year Ended October 31, |
|  | 2025<sup>(a),(b),(c)</sup> | 2024<sup>(a)</sup> |
| **Capital Share Transactions (Shares):** |  |  |
| **ETF shares** |  |  |
| Shares sold | &nbsp;&nbsp;&nbsp;&nbsp; 1160001 | &nbsp;&nbsp;&nbsp;&nbsp; - |
| Shares issued in connection with reorganization—Note 1 | &nbsp;&nbsp;&nbsp;&nbsp; 3645886 | &nbsp;&nbsp;&nbsp;&nbsp; - |
| Shares redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (1420002) | &nbsp;&nbsp;&nbsp;&nbsp; - |
| **Net Increase (Decrease) in Shares Outstanding** | &nbsp;&nbsp;&nbsp;&nbsp; **3385885** | &nbsp;&nbsp;&nbsp;&nbsp; **-** |
| **Class A**<sup>(d),(e)</sup> <br>|  |  |
| Shares sold | &nbsp;&nbsp;&nbsp;&nbsp; 91405 | &nbsp;&nbsp;&nbsp;&nbsp; 38569 |
| Shares issued for distributions reinvested | &nbsp;&nbsp;&nbsp;&nbsp; 672382 | &nbsp;&nbsp;&nbsp;&nbsp; 162169 |
| Shares redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (3361607) | &nbsp;&nbsp;&nbsp;&nbsp; (208100) |
| **Net Increase (Decrease) in Shares Outstanding** | &nbsp;&nbsp;&nbsp;&nbsp; **(2597820)** | &nbsp;&nbsp;&nbsp;&nbsp; **(7362)** |
| **Class C**<sup>(d),(e)</sup> <br>|  |  |
| Shares sold | &nbsp;&nbsp;&nbsp;&nbsp; 7 | &nbsp;&nbsp;&nbsp;&nbsp; 8069 |
| Shares issued for distributions reinvested | &nbsp;&nbsp;&nbsp;&nbsp; 26323 | &nbsp;&nbsp;&nbsp;&nbsp; 7002 |
| Shares redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (108304) | &nbsp;&nbsp;&nbsp;&nbsp; (22557) |
| **Net Increase (Decrease) in Shares Outstanding** | &nbsp;&nbsp;&nbsp;&nbsp; **(81974)** | &nbsp;&nbsp;&nbsp;&nbsp; **(7486)** |
| **Class I**<sup>(e)</sup> <br>|  |  |
| Shares sold | &nbsp;&nbsp;&nbsp;&nbsp; 2915257 | &nbsp;&nbsp;&nbsp;&nbsp; 50074 |
| Shares issued for distributions reinvested | &nbsp;&nbsp;&nbsp;&nbsp; 202801 | &nbsp;&nbsp;&nbsp;&nbsp; 52819 |
| Shares redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (3839516) | &nbsp;&nbsp;&nbsp;&nbsp; (143743) |
| **Net Increase (Decrease) in Shares Outstanding** | &nbsp;&nbsp;&nbsp;&nbsp; **(721458)** | &nbsp;&nbsp;&nbsp;&nbsp; **(40850)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> The fund commenced offering ETF shares after the close of business March 28, 2025. The amounts disclosed include those of the Predecessor Fund. See Note 1 for additional information on the reorganization. 

<sup>(b)</sup> On March 14, 2025, the Predecessor Fund redesignated Class A and Class C shares into Class I shares.

<sup>(c)</sup> As of the close of business on March 28, 2025, pursuant to an Agreement and Plan of Reorganization (the "Agreement") previously approved by the Board of Trustees (the "Board"), all of the assets, subject to the liabilities, of the Predecessor Fund, a series of BNY Mellon Investment Funds IV, Inc., were transferred to the fund in a tax free exchange for ETF shares. Shareholders of Class I shares of the Predecessor Fund received ETF shares of the fund. 

<sup>(d)</sup> During the period ended October 31, 2025, 540 Class C shares representing $18,591 were automatically converted to 474 Class A shares and during the period ended October 31, 2024, 1,791 Class C shares representing $62,756 were automatically converted to 1,596 Class A shares. 

<sup>(e)</sup> During the period ended October 31, 2025, 76,332 Class C shares representing $2,012,870 were converted to 64,702 Class I shares and 2,832,348 Class A shares representing $87,547,888 were converted to 2,814,140 Class I shares. 

See notes to financial statements.

**8**

------

FINANCIAL HIGHLIGHTS

Please note that financial highlights information in the following table for the fund's ETF shares represents the financial highlights of the Predecessor Fund (Class I shares) for periods prior to the commencement of operations of the Fund's ETF shares on March 28, 2025. On that date, all of the assets of the Predecessor Fund were transferred to the fund in exchange for ETF shares in a tax-free reorganization. Accordingly, financial highlights for periods after March 28, 2025 represent the results of the fund's ETF shares.

All information (except portfolio turnover rate) reflects financial results for a single fund share. Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period, and redemption at net asset value on the last day of the period. Net asset value total return includes adjustments in accordance with accounting principles generally accepted in the United States of America and as such, the net asset value for financial reporting purposes and the returns based upon those net asset values may differ from the net asset value and returns for shareholder transactions. Market price total return is calculated assuming an initial investment made at the market price at the beginning of the period, reinvestment of all dividends and distributions at market price during the period, and sale at the market price on the last day of the period.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Year Ended October 31, | Year Ended October 31, | Year Ended October 31, | Year Ended October 31, | Year Ended October 31, |
|  | 2025 | 2024 | 2023 | 2022 | 2021 |
| **Per Share Data ($):**<sup>(a)</sup>  | **Per Share Data ($):**<sup>(a)</sup>  |  |  |  |  |
| Net asset value, beginning of period | &nbsp;&nbsp;&nbsp;&nbsp;41.70 | &nbsp;&nbsp;&nbsp;&nbsp;36.13 | &nbsp;&nbsp;&nbsp;&nbsp;35.23 | &nbsp;&nbsp;&nbsp;&nbsp;44.65 | &nbsp;&nbsp;&nbsp;&nbsp;33.90 |
| Investment Operations: | Investment Operations: |  |  |  |  |
| Net investment income<sup>(b)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; .23 | &nbsp;&nbsp;&nbsp;&nbsp; .19 | &nbsp;&nbsp;&nbsp;&nbsp; .24 | &nbsp;&nbsp;&nbsp;&nbsp; .18 | &nbsp;&nbsp;&nbsp;&nbsp; .14 |
| Net realized and unrealized gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp;4.74 | &nbsp;&nbsp;&nbsp;&nbsp;8.12 | &nbsp;&nbsp;&nbsp;&nbsp;3.43 | &nbsp;&nbsp;&nbsp;&nbsp; (7.84)<br>| &nbsp;&nbsp;&nbsp;&nbsp;13.04 |
| Total from Investment Operations | &nbsp;&nbsp;&nbsp;&nbsp;4.97 | &nbsp;&nbsp;&nbsp;&nbsp;8.31 | &nbsp;&nbsp;&nbsp;&nbsp;3.67 | &nbsp;&nbsp;&nbsp;&nbsp; (7.66)<br>| &nbsp;&nbsp;&nbsp;&nbsp;13.18 |
| Distributions: |  |  |  |  |  |
| Dividends from net investment income | &nbsp;&nbsp;&nbsp;&nbsp; (.24)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (.21)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (.23)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (.04)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (.15)<br>|
| Dividends from net realized gain on investments | &nbsp;&nbsp;&nbsp;&nbsp; (10.20)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2.53)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2.54)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1.72)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2.28)<br>|
| Total Distributions | &nbsp;&nbsp;&nbsp;&nbsp; (10.44)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2.74)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2.77)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1.76)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2.43)<br>|
| Net asset value, end of period | &nbsp;&nbsp;&nbsp;&nbsp;36.23 | &nbsp;&nbsp;&nbsp;&nbsp;41.70 | &nbsp;&nbsp;&nbsp;&nbsp;36.13 | &nbsp;&nbsp;&nbsp;&nbsp;35.23 | &nbsp;&nbsp;&nbsp;&nbsp;44.65 |
| Market value, end of period | &nbsp;&nbsp;&nbsp;&nbsp;36.26 | &nbsp;&nbsp;&nbsp;&nbsp; N/A | &nbsp;&nbsp;&nbsp;&nbsp; N/A | &nbsp;&nbsp;&nbsp;&nbsp; N/A | &nbsp;&nbsp;&nbsp;&nbsp; N/A |
| **Total Return (%)** | &nbsp;&nbsp;&nbsp;&nbsp;15.21 | &nbsp;&nbsp;&nbsp;&nbsp;24.12 | &nbsp;&nbsp;&nbsp;&nbsp;10.95 | &nbsp;&nbsp;&nbsp;&nbsp; (17.90)<br>| &nbsp;&nbsp;&nbsp;&nbsp;40.76 |
| **Market Price Total Return (%)** | &nbsp;&nbsp;&nbsp;&nbsp;15.30 | &nbsp;&nbsp;&nbsp;&nbsp; N/A | &nbsp;&nbsp;&nbsp;&nbsp; N/A | &nbsp;&nbsp;&nbsp;&nbsp; N/A | &nbsp;&nbsp;&nbsp;&nbsp; N/A |
| **Ratios/Supplemental Data (%):** | **Ratios/Supplemental Data (%):** |  |  |  |  |
| Ratio of total expenses to average net assets | &nbsp;&nbsp;&nbsp;&nbsp; .79 <br><sup>(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp; .97 | &nbsp;&nbsp;&nbsp;&nbsp; .97 | &nbsp;&nbsp;&nbsp;&nbsp; .96 | &nbsp;&nbsp;&nbsp;&nbsp; .96 |
| Ratio of net expenses to average net assets<sup>(d)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; .66 <br><sup>(c),(e),(f)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp; .88 <br><sup>(e)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp; .95 | &nbsp;&nbsp;&nbsp;&nbsp; .95 | &nbsp;&nbsp;&nbsp;&nbsp; .95 |
| Ratio of net investment income to average net assets<sup>(d)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; .46 <br><sup>(c),(e),(f)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp; .47 <br><sup>(e)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp; .67 | &nbsp;&nbsp;&nbsp;&nbsp; .46 | &nbsp;&nbsp;&nbsp;&nbsp; .36 |
| Portfolio Turnover Rate<sup>(g)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;14.05 | &nbsp;&nbsp;&nbsp;&nbsp;14.92 | &nbsp;&nbsp;&nbsp;&nbsp;1.73 | &nbsp;&nbsp;&nbsp;&nbsp;7.55 | &nbsp;&nbsp;&nbsp;&nbsp;4.27 |
| **Net Assets, end of period ($ x 1,000)** | &nbsp;&nbsp;&nbsp;&nbsp; 122686 | &nbsp;&nbsp;&nbsp;&nbsp; 30087 | &nbsp;&nbsp;&nbsp;&nbsp; 27543 | &nbsp;&nbsp;&nbsp;&nbsp; 21512 | &nbsp;&nbsp;&nbsp;&nbsp; 25691 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> The fund commenced offering ETF shares after the close of business March 28, 2025. The amounts disclosed include those of the Predecessor Fund. See Note 1 for additional information on the reorganization. 

<sup>(b)</sup> Based on average shares outstanding.

<sup>(c)</sup> Amount does not include the expenses of the underlying funds.

<sup>(d)</sup> Amount inclusive of Directors' fees reimbursed by BNY Mellon Investment Adviser, Inc. For periods beginning on or after March 28, 2025, following the Fund's reorganization into an ETF, the fee is paid by BNY Mellon ETF Investment Adviser, LLC. 

<sup>(e)</sup> Amount inclusive of reduction in expenses due to undertaking.

<sup>(f)</sup> Amount inclusive of reduction in Distribution Plan fees.

<sup>(g)</sup> Portfolio turnover rate does not include securities received or delivered from processing creations or redemptions.

See notes to financial statements.

**9**

------

NOTES TO FINANCIAL STATEMENTS

**NOTE 1—**

**Organization:**

BNY Mellon Concentrated Growth ETF (the "fund") is a separate non-diversified series of BNY Mellon ETF Trust II (the "Trust"), which is registered as a Massachusetts business trust under the Investment Company Act of 1940, as amended (the "Act"), as an open-ended management investment company. The Trust operates as a series company currently consisting of two series, including the fund. The investment objective of the fund is to seek long-term capital appreciation. BNY Mellon ETF Investment Adviser, LLC (the "Adviser"), a wholly-owned subsidiary of The Bank of New York Mellon Corporation ("BNY"), serves as the fund's investment adviser. Fayez Sarofim & Co., LLC (the "Sub-Adviser"), serves as the fund's sub-adviser. The Bank of New York Mellon, a subsidiary of BNY and an affiliate of the Adviser, serves as administrator, custodian and transfer agent with the Trust. BNY Mellon Securities Corporation (the "Distributor"), a wholly-owned subsidiary of the Adviser, is the distributor of the fund's shares.

As of the close of business on March 28, 2025, pursuant to the Agreement previously approved by the Board, all of the assets, subject to the liabilities, of the Predecessor Fund, a series of BNY Mellon Investment Funds IV, Inc., were transferred to the fund in a tax free exchange for ETF shares. Shareholders of Class I shares of the Predecessor Fund received ETF shares of the fund in each case in an amount equal to the aggregate net asset value of their investment in the Predecessor Fund at the time of the exchange. On March 14, 2025, the Predecessor Fund redesignated Class A and Class C shares into Class I shares. The net asset value of the fund's shares on the close of business on March 28, 2025, after the reorganization was $30.69 for Class I shares, and a total of 3,645,886 Class I shares, representing net assets of $111,903,401 (including $65,555,300 net appreciation on investments) issued to shareholders of the Predecessor Fund in the exchange. The fund is the accounting survivor of the Predecessor Fund and the Predecessor Fund's historical performance is presented for periods through March 28, 2025. BNY Mellon Investment Adviser, Inc. ("Predecessor Fund Adviser") paid all of the reorganization fees attributable to the reorganization.

The shares of the fund are referred to herein as "Shares" or "Fund Shares." Fund Shares are listed and traded on NYSE Arca, Inc. The market price of each Share may differ to some degree from the fund's net asset value ("NAV"). Unlike conventional mutual funds, the fund issues and redeems Shares on a continuous basis, at NAV, only in a large specified number of Shares, each called a "Creation Unit". Creation Units are issued and redeemed principally in exchange for the deposit or delivery of a basket of securities and/or cash. Except when aggregated in Creation Units by Authorized Participants, the Shares are not individually redeemable securities of the fund. Individual Fund Shares may only be purchased and sold on the NYSE Arca, Inc., other national securities exchanges, electronic crossing networks and other alternative trading systems through your broker-dealer at market prices. Because Fund Shares trade at market prices rather than at NAV, Fund Shares may trade at a price greater than NAV (premium) or less than NAV (discount). When buying or selling Shares in the secondary market, you may incur costs attributable to the difference between the highest price a buyer is willing to pay to purchase Shares of the fund (bid) and the lowest price a seller is willing to accept for Shares of the fund (ask).

**NOTE 2—**

**Significant Accounting Policies:**

The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") is the exclusive reference of authoritative U.S. generally accepted accounting principles ("GAAP") recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the SEC under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund's financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The Trust enters into contracts that contain a variety of indemnifications. The fund's maximum exposure under these arrangements is unknown. The funds do not anticipate recognizing any loss related to these arrangements.

**(a) Portfolio valuation:** The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

**10**

------

NOTES TO FINANCIAL STATEMENTS (continued)

Various inputs are used in determining the value of the fund's investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

**Level 1**—unadjusted quoted prices in active markets for identical investments.

**Level 2**—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

**Level 3**—significant unobservable inputs (including the fund's own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund's investments are as follows:

The Board has designated the Adviser as the fund's valuation designee to make all fair value determinations with respect to the fund's portfolio of investments, subject to the Board's oversight and pursuant to Rule 2a-5 under the Act.

Investments in equity securities, including shares of REITs and ETFs (but not including investments in other open-end registered investment companies), generally are valued at the last sales price on the day of valuation of the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Association of Securities Dealers Automated Quotation System ("NASDAQ") markets generally will be valued at the official closing price. If there are no transactions in a security, or no official closing prices for a NASDAQ market-listed security on that day, the security will be valued at the average of the most recent bid and asked prices. Bid price is used when no asked price is available. Open short positions for which there is no sale price on a given day are valued at the lowest asked price. Investments in other open-end investment companies are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to reflect fair value accurately, are valued at fair value as determined in good faith based on procedures approved by the Board. Fair value of investments may be determined by valuation designee using such information as it deems appropriate under the circumstances. The factors that may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and are generally categorized within Level 3 of the fair value hierarchy.

The following is a summary of the inputs used as of October 31, 2025 in valuing the fund's investments:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1 -** <br>**Unadjusted** <br>**Quoted Prices**<br>| **Level 2- Other** <br>**Significant** <br>**Observable Inputs**<br>| **Level 3-** <br>**Significant** <br>**Unobservable** <br>**Inputs**<br>| **Total** |
| **Assets ($)** |  |  |  |  |
| Investments in Securities:<sup>†</sup> <br>|  |  |  |  |
| Equity Securities - Common Stocks | &nbsp;&nbsp; 118190242 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **118190242** |
| Investment Companies | &nbsp;&nbsp; 4442801 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **4442801** |
|  | &nbsp;&nbsp; **122633043** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **122633043** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>†</sup> See Schedule of Investments for additional detailed categorizations, if any.

**(b) Foreign currency transactions:** The fund does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in the market prices of securities held. Such fluctuations are included with the net realized and unrealized gain or loss on investments.

Net realized foreign exchange gains or losses arise from sales of foreign currencies, currency gains or losses realized on securities transactions between trade and settlement date, and the difference between the amounts of dividends, interest and foreign withholding taxes

**11**

------

NOTES TO FINANCIAL STATEMENTS (continued)

recorded on the fund's books and the U.S. dollar equivalent of the amounts actually received or paid. Net unrealized foreign exchange gains and losses arise from changes in the value of assets and liabilities other than investments resulting from changes in exchange rates. Foreign currency gains and losses on foreign currency transactions are also included with net realized and unrealized gain or loss on investments.

**Foreign taxes:** The fund may be subject to foreign taxes (a portion of which may be reclaimable) on income, stock dividends, realized and unrealized capital gains on investments or certain foreign currency transactions. Foreign taxes are recorded in accordance with the applicable foreign tax regulations and rates that exist in the foreign jurisdictions in which the fund invests. These foreign taxes, if any, are paid by the fund and are reflected in the Statement of Operations, if applicable. Foreign taxes payable or deferred or those subject to reclaims as of October 31, 2025, if any, are disclosed in the fund's Statement of Assets and Liabilities.

**(c) Securities transactions and investment income:** Securities transactions are recorded on a trade date basis. Realized gains and losses from securities transactions are recorded on the identified cost basis. Dividend income is recognized on the ex-dividend date and interest income, including, where applicable, accretion of discount and amortization of premium on investments, is recognized on the accrual basis.

Pursuant to a securities lending agreement with BNY, the fund may lend securities to qualified institutions. It is the fund's policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by the Adviser, or U.S. Government and Agency securities. Any non-cash collateral received cannot be sold or re-pledged by the fund, except in the event of borrower default, and is not reflected in the Statement of Assets and Liabilities. The securities on loan, if any, are also disclosed in the fund's Schedule of Investments. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a result of the lending transaction. Should a borrower fail to return the securities in a timely manner, BNY is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund's rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis. During the period ended October 31, 2025, BNY earned $1,282 from the lending of the fund's portfolio securities, pursuant to the securities lending agreement.

For financial reporting purposes, the fund elects not to offset assets and liabilities subject to a securities lending agreement, if any, in the Statement of Assets and Liabilities. Therefore, all qualifying transactions are presented on a gross basis in the Statement of Assets and Liabilities. As of October 31, 2025, the fund had no securities on loan.

**(d) Affiliated issuers:** Investments in other investment companies advised by the Adviser or its affiliates are considered "affiliated" under the Act.

**(e) Market Risk:** The value of the securities in which the fund invests may be affected by political, regulatory, economic and social developments, and developments that impact specific economic sectors, industries or segments of the market. In addition, turbulence in financial markets and reduced liquidity in equity, credit and/or fixed-income markets may negatively affect many issuers, which could adversely affect the fund. Global economies and financial markets are becoming increasingly interconnected, and conditions and events in one country, region or financial market may adversely impact issuers in a different country, region or financial market. These risks may be magnified if certain events or developments adversely interrupt the global supply chain; in these and other circumstances, such risks might affect companies world-wide.

**Foreign Investment Risk**: Because the fund invests in foreign securities, the fund's performance will be influenced by political, social and economic factors affecting investments in foreign issuers. Special risks associated with investments in foreign issuers include exposure to currency fluctuations, less liquidity, less developed or less efficient trading markets, lack of comprehensive company information, political and economic instability and differing auditing and legal standards. The imposition of sanctions, confiscations, trade restrictions (including tariffs) and other government restrictions by the United States and other governments, or problems in share registration, settlement or custody, may result in losses for the fund. Investments denominated in foreign currencies are subject to the risk that such currencies will decline in value relative to the U.S. dollar and affect the value of these investments held by the fund. To the extent securities held by the fund trade in a market that is closed when the exchange on which the fund's shares trade is open, there may be deviations between the current price of a security and the last quoted price for the security in the closed foreign market. These deviations could result in the fund experiencing premiums or discounts greater than those of ETFs that invest in domestic securities. To the extent the fund's investments are focused in a limited number of foreign countries, the fund's performance could be more volatile than that of more geographically diversified funds.

**12**

------

NOTES TO FINANCIAL STATEMENTS (continued)

**Non-Diversification Risk:** The fund is non-diversified, which means that the fund may invest a relatively high percentage of its assets in a limited number of issuers. Therefore, the fund's performance may be more vulnerable to changes in the market value of a single issuer or group of issuers and more susceptible to risks associated with a single economic, political or regulatory occurrence than a diversified fund.

**Growth Stock Risk:**The fund invests in stocks of companies the sub-adviser believes are growth companies (growth stocks). The prices of growth stocks may be based largely on expectations of future earnings, and their prices can decline rapidly and significantly in reaction to negative news. Growth stocks may underperform value stocks and stocks in other broad style categories (and the stock market as a whole) over any period of time and may shift in and out of favor with investors generally, sometimes rapidly, depending on changes in market, economic, and other factors.

**Authorized Participants, Market Makers and Liquidity Providers Risk:** The fund has a limited number of financial institutions that may act as Authorized Participants, which are responsible for the creation and redemption activity for the fund. In addition, there may be a limited number of market makers and/or liquidity providers in the marketplace. To the extent either of the following events occur, fund shares may trade at a material discount to net asset value and possibly face delisting: (i) Authorized Participants exit the business or otherwise become unable to process creation and/or redemption orders and no other Authorized Participants step forward to perform these services, or (ii) market makers and/or liquidity providers exit the business or significantly reduce their business activities and no other entities step forward to perform their functions.

**(f) Dividends and distributions to shareholders:** Dividends and distributions are recorded on the ex-dividend date. Dividends from net investment income are normally declared and paid quarterly. Dividends from net realized capital gains, if any, are normally declared and paid annually, but the fund may make distributions on a more frequent basis to comply with the distribution requirements of the Internal Revenue Code of 1986, as amended (the "Code"). To the extent that net realized capital gains can be offset by capital loss carryovers, it is the policy of the fund not to distribute such gains. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP.

**(g) Federal income taxes:** It is the policy of the fund to continue to qualify as a regulated investment company, if such qualification is in the best interests of its shareholders, by complying with the applicable provisions of the Code, and to make distributions of taxable income and net realized capital gain sufficient to relieve it from substantially all federal income and excise taxes.

As of and during the period ended October 31, 2025, the fund did not have any liabilities for any uncertain tax positions. The fund recognizes interest and penalties, if any, related to uncertain tax positions as income tax expense in the Statement of Operations. During the period ended October 31, 2025, the fund did not incur any interest or penalties.

Each tax year in the four-year period ended October 31, 2025 remains subject to examination by the Internal Revenue Service and state taxing authorities.

At October 31, 2025, the components of accumulated earnings on a tax basis were as follows: undistributed ordinary income $60,407 and unrealized appreciation $60,462,088.

The tax character of distributions paid to shareholders during the fiscal years ended October 31, 2025 and October 31, 2024 were as follows: ordinary income $702,070 and $435,166, and long-term capital gains $34,658,490 and $8,596,513, respectively.

During the period ended October 31, 2025, as a result of permanent book to tax differences, primarily due to in-kind redemptions, the fund decreased total distributable earnings (loss) by $27,248,509 and increased paid-in capital by the same amount. Net assets and net asset value per share were not affected by this reclassification.

**(h) Operating segment reporting:** In this reporting period, the fund adopted FASB Accounting Standards Update 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures ("ASU 2023-07"). Adoption of the new standard impacted financial statement disclosures only and did not affect the fund's financial position or the results of its operations. The ASU 2023-07 is effective for public entities for fiscal years beginning after December 15, 2023, and requires retrospective application for all prior periods presented within the financial statements.

Since its commencement, the fund operates and is managed as a single reportable segment deriving returns in the form of dividends, interest and/or gains from the investments made in pursuit of its single stated investment objective as outlined in the fund's prospectus. The accounting policies of the fund are consistent with those described in these Notes to Financial Statements. The chief operating decision maker ("CODM") is represented by BNY Investments. The CODM is comprised of Senior Management and Directors of BNY Investments. The CODM considers net increase in net assets resulting from operations in deciding whether to purchase additional investments or to make distributions to fund shareholders. Detailed financial information for the fund is disclosed within these financial

**13**

------

NOTES TO FINANCIAL STATEMENTS (continued)

statements with total assets and liabilities disclosed on the Statement of Assets and Liabilities, investments held on the Schedule of Investments, results of operations and significant segment expenses on the Statement of Operations and other information about the fund's performance, including total return, portfolio turnover and ratios within the Financial Highlights.

**NOTE 3—**

**Bank Lines of Credit:**

Prior to March 28, 2025, the Predecessor Fund had participated with other long-term open-end funds managed by BNY Mellon Investment Adviser, Inc. (the "Predecessor Fund Adviser") in a $738 million unsecured credit facility led by Citibank, N.A. (the "Citibank Credit Facility") and a $300 million unsecured credit facility provided by BNY (the "BNY Credit Facility"), each to be utilized primarily for temporary or emergency purposes, including the financing of redemptions (each, a "Facility"). The Citibank Credit Facility is available in two tranches: (i) Tranche A is in an amount equal to $618 million and is available to all long-term open-ended funds, including the Predecessor Fund, and (ii) Tranche B is an amount equal to $120 million and is available only to BNY Mellon Floating Rate Income Fund, a series of BNY Mellon Investment Funds IV, Inc. In connection therewith, the Predecessor Fund has agreed to pay its pro rata portion of commitment fees for Tranche A of the Citibank Credit Facility and the BNY Credit Facility. Interest was charged to the Predecessor Fund based on rates determined pursuant to the terms of the respective Facility at the time of borrowing. During the period ended October 31, 2025, the Predecessor Fund did not borrow under either Facility.

**NOTE 4—**

**Management Fee, Sub-Advisory Fee and Other Transactions with Affiliates:**

**(a)** Pursuant to a management agreement with the Adviser, the management fee is computed at the annual rate of .50% of the value of the fund's average daily net assets and is payable monthly. Prior to March 28, 2025, the Predecessor Fund Adviser fee was computed at an annual rate of .95% of the Predecessor Fund's average daily net assets, and was payable monthly. The fund's management agreement provides that the Adviser pays substantially all expenses of the fund, except for the management fees, payments under the fund's 12b-1 plan (if any), interest expenses, taxes, acquired fund fees and expenses, brokerage commissions, costs of holding shareholder meetings, fees and expenses associated with the fund's securities lending program, and litigation and potential litigation and other extraordinary expenses not incurred in the ordinary course of the fund's business. The Adviser may from time to time voluntarily waive and/or reimburse fees or expenses in order to limit total annual fund operating expenses. Any such voluntary waiver or reimbursement may be eliminated by the Adviser at any time. During the period ended October 31, 2025, there was no reduction in expenses pursuant to the undertaking.

The Predecessor Fund Adviser had agreed in its investment management agreement with the Predecessor Fund to: (1) pay all of the direct expenses, except management fees, Rule 12b-1 Distribution/Service Plan fees and certain other expenses, including the fees and expenses of the independent board members and independent counsel to the Predecessor Fund and to the independent board members, and (2) reduce its fees pursuant to the management agreement in an amount equal to the Predecessor Fund's allocable portion of the fees and expenses of the independent board members and independent counsel to the Predecessor Fund and to the independent board members. These provisions in the management agreement may not be amended without the approval of the fund's shareholders. Prior to the reorganization of the fund, fees reimbursed by the Predecessor Fund Adviser amounted to $7,055.

The Predecessor Fund Adviser had agreed to waive receipt of the Predecessor Fund's 12b-1 Distribution fee of the value of the Predecessor Fund's average daily net assets. The reduction in expenses, pursuant to the undertaking, amounted to $105,637 prior to the reorganization.

The Predecessor Fund Adviser had contractually agreed, from November 1, 2024 through undefined, to waive receipt of a portion of the Predecessor Fund's management fee, in the amount of .10% of the value of the funds average daily net assets. On undefined, the Predecessor Fund Adviser had terminated this waiver agreement. The reduction in expenses, pursuant to the undertaking, amounted to $55,093 prior to the reorganization.

Effective March 28, 2025, pursuant to a sub-investment advisory agreement between the Adviser and the Sub-Adviser, the Sub-Adviser serves as the fund's sub-adviser responsible for the day-to-day management of the fund's portfolio. The Adviser pays the Sub-Adviser a monthly fee at an annual percentage of the value of the fund's average daily net assets. The Adviser has obtained an exemptive order from the SEC (the "Order"), upon which the fund may rely, to use a manager of managers approach that permits the Adviser, subject to certain conditions and approval by the Board, to enter into and materially amend sub-investment advisory agreements with one or more sub-advisers who are either unaffiliated with the Adviser or are wholly-owned subsidiaries (as defined under the Act) of the Adviser's ultimate parent company, BNY, without obtaining shareholder approval. The Order also allows the fund to disclose the sub-advisory fee paid by the Adviser to any unaffiliated sub-adviser in the aggregate with other unaffiliated sub-advisers in documents filed with the SEC and provided to shareholders. In addition, pursuant to the Order, it is not necessary to disclose the sub-advisory fee payable by the

**14**

------

NOTES TO FINANCIAL STATEMENTS (continued)

Adviser separately to a sub-adviser that is a wholly-owned subsidiary of BNY in documents filed with the SEC and provided to shareholders; such fees are to be aggregated with fees payable to the Adviser. The Adviser has ultimate responsibility (subject to oversight by the Board) to supervise any sub-adviser and recommend the hiring, termination, and replacement of any sub-adviser to the Board.

Pursuant to a sub-investment advisory agreement between the Adviser and the Sub-Adviser, the Adviser (not the fund) pays the Sub-Adviser a monthly fee at an annual rate of .2175% of the value of the fund's average daily net assets. Prior to March 28, 2025, under a similar agreement between the Predecessor Fund Adviser and the Sub-Adviser, the Predecessor Fund Adviser paid the Sub-Adviser the same fee rate.

**(b)** Under the Predecessor Fund's Distribution Plans adopted pursuant to Rule 12b-1 (the "Distribution Plans") under the Act, Class A shares paid annually up to .25% of the value of its average daily net assets to compensate the Distributor and its affiliates for shareholder servicing activities and expenses primarily intended to result in the sale of Class A shares. The Distributor may compensate Service Agents in respect of distribution related services with regard to the Predecessor Fund and/or shareholder services to the Service Agents' clients that held Class A shares. Class C shares paid the Distributor for distributing its shares at an annual rate of .75% of the value of its average daily net assets of Class C shares. The Distributor may pay one or more Service Agents for distribution related services, and determines the amounts, if any, to be paid to Service Agents and the basis on which such payments are made. Class C shares were also subject to a service plan adopted pursuant to Rule 12b-1 (the "Service Plan"), under which Class C shares paid the Distributor for providing certain services to the holders of their shares, a fee at an annual rate of .25% of the value of the average daily net assets of Class C shares. Services included personal services relating to shareholder accounts, such as answering shareholder inquiries regarding the Predecessor Fund, and providing services related to the maintenance of shareholder accounts. The Distributor may make payments to certain Service Agents in respect of these services. During the period ended October 31, 2025, Class A and Class C shares were charged $97,627 and $8,010, respectively, pursuant to their Distribution Plans. During the period ended October 31, 2025, Class C shares were charged $2,670 pursuant to the Service Plan.

The fund has an arrangement with The Bank of New York Mellon (the "Custodian"), a subsidiary of BNY and an affiliate of the Adviser, whereby the fund will receive interest income or be charged overdraft fees when cash balances are maintained. For financial reporting purposes, the fund includes this interest income and overdraft fees, if any, as interest income in the Statement of Operations.

The components of "Due to BNY Mellon ETF Investment Adviser, LLC" in the Statement of Assets and Liabilities consist of: Management fee of $51,800.

**(c)** Each Board member serves as a Board member of each fund within the Trust. The Board members are not compensated directly by the fund. The Board members are paid by the Adviser from the unitary management fees paid to the Adviser by the funds within the Trust, including the fund.

**NOTE 5—**

**Securities Transactions:**

The aggregate amount of purchases and sales of investment securities, excluding short-term securities and in-kind transactions, if any, during the period ended October 31, 2025, amounted to $17,385,641 and $48,022,625, respectively.

At October 31, 2025, the cost of investments for federal income tax purposes was $62,170,955; accordingly, accumulated net unrealized appreciation on investments was $60,462,088, consisting of $61,286,775 gross unrealized appreciation and $824,687 gross unrealized depreciation.

**NOTE 6—**

**Shareholder Transactions:**

The fund issues and redeems its shares on a continuous basis, at NAV, to certain institutional investors known as "Authorized Participants" (typically market makers or other broker-dealers) only in a large specified number of shares called a Creation Unit. Except when aggregated in Creation Units, shares of the fund are not redeemable. The value of the fund is determined once each business day. The Creation Unit size for the fund may change. Authorized Participants will be notified of such change. Creation Unit transactions may be made in-kind, for cash, or for a combination of securities and cash. The principal consideration for creations and redemptions for the fund is in-kind, although this may be revised at any time without notice. The Trust issues and sells shares of the fund only: in Creation Units on a continuous basis through the Distributor, without a sales load, at their NAV per share determined after receipt of an order, on any Business Day, in proper form pursuant to the terms of the Authorized Participant Agreement. Transactions in capital shares for the fund are disclosed in detail in the Statement of Changes in Net Assets. The consideration for the purchase of Creation Units of the fund may consist of the in-kind deposit of a designated portfolio of securities and a specified amount of cash. Investors purchasing and redeeming Creation Units may pay a purchase transaction fee and a redemption transaction fee directly to the Trust and/or custodian to

**15**

------

NOTES TO FINANCIAL STATEMENTS (continued)

offset transfer and other transaction costs associated with the issuance and redemption of Creation Units, including Creation Units for cash. The Adviser or its affiliates (the "Selling Shareholder") may purchase Creation Units through a broker-dealer to "seed" (in whole or in part) funds as they are launched or may purchase shares from broker-dealers or other investors that have previously provided "seed" for funds when they were launched or otherwise in secondary market transactions. Because the Selling Shareholder may be deemed an affiliate of such funds, the fund shares are being registered to permit the resale of these shares from time to time after purchase. The fund will not receive any of the proceeds from resale by the Selling Shareholders of these fund shares. An additional variable fee may be charged for certain transactions. Such variable charges, if any, are included in "Transaction fees" on the Statement of Changes in Net Assets.

**In-kind Redemptions:** For financial reporting purposes, in-kind redemptions are treated as sales of securities resulting in realized capital gains or losses to the fund. Because such gains or losses are not taxable to the fund and are not distributed to existing fund shareholders, the gains or losses are reclassified from accumulated net realized gain (loss) to paid-in capital at the end of the fund's tax year. These reclassifications have no effect on net assets or net asset value per share. During the period ended October 31, 2025, the fund had in-kind transactions associated with creations of $32,705,662 and redemptions of $41,409,984.

**16**

------

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Trustees of BNY Mellon Concentrated Growth ETF

Opinion on the Financial Statements

We have audited the accompanying statement of assets and liabilities of BNY Mellon Concentrated Growth ETF (the "Fund") (one of the funds constituting BNY Mellon ETF Trust II (the "Trust")), including the schedule of investments, as of October 31, 2025, and the related statements of operations, changes in net assets, and the financial highlights for the year then ended and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund (one of the funds constituting BNY Mellon ETF Trust II) at October 31, 2025, the results of its operations, the changes in its net assets and its financial highlights for the year then ended, in conformity with U.S. generally accepted accounting principles.

The statement of changes in net assets for the year ended October 31, 2024, and the financial highlights for each of the years in the four year period then ended, were audited by another independent registered public accounting firm whose report, dated December 20, 2024, expressed an unqualified opinion on that statement of changes in net assets and those financial highlights.

Basis for Opinion

These financial statements are the responsibility of the Trust's management. Our responsibility is to express an opinion on the Fund's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Trust in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Trust is not required to have, nor were we engaged to perform, an audit of the Trust's internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Trust's internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of October 31, 2025, by correspondence with the custodian, brokers and others; when replies were not received from brokers and others, we performed other auditing procedures. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provide a reasonable basis for our opinion. ![](imga56806dd2.gif)

We have served as the auditor of one or more investment companies in the BNY Mellon Family of Funds since at least 1957, but we are unable to determine the specific year.

New York, New York

December 24, 2025

**17**

------

IMPORTANT TAX INFORMATION (Unaudited)

Form 1099-DIV, Form 1042-S and other year–end tax information provide shareholders with actual calendar year amounts that should be included in their tax returns. Shareholders should consult their tax advisers.

The following distribution information is being provided as required by the Internal Revenue Code or to meet a specific state's requirement.

The fund designates the following amounts or, if subsequently determined to be different, the maximum amount allowable for its fiscal period ended October 31, 2025:

For federal tax purposes the fund hereby reports 100% of ordinary income dividends paid during the fiscal period ended October 31, 2025 as qualified dividend income and 88.46% as corporate dividends received deduction.

**18**

------

Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**(a)** The Fund, which is a series of BNY Mellon ETF Trust II (the "Trust"), is the successor to the BNY Mellon Tax Managed Growth Fund, a series of BNY Mellon Investment Funds IV, Inc. (the "Predecessor Fund"). The Fund acquired the assets and assumed the liabilities of the Predecessor Fund on March 28, 2025 (the "Reorganization"). Upon completion of the Reorganization, the Fund commenced operations and assumed the accounting history of the Predecessor Fund. KPMG LLP ("KPMG") was the independent registered public accounting firm for the Predecessor Fund until the Reorganization on March 28, 2025.

During each of the two fiscal years ended October 31, 2024 and October 31, 2023, and the subsequent interim period through March 28, 2025, there were no disagreements with KPMG on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction of KPMG, would have caused KPMG to make reference to the subject matter of the disagreement in connection with KPMG's reports on the financial statements. In addition, there have been no reportable events of the kind described in Item 304(a)(1)(v) of Regulation S-K under the Securities Exchange Act of 1934 with respect to the Predecessor Fund.

The audit reports of KPMG on the financial statements of the Predecessor Fund as of and for the fiscal years ended October 31, 2024 and October 31, 2023 did not contain an adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope, or accounting principles.

The Fund provided KPMG with a copy of the foregoing disclosures and has requested that KPMG furnish the Fund with a letter addressed to the U.S. Securities and Exchange Commission (the "SEC") stating whether KPMG agrees with the above statements. A copy of the letter from KPMG is filed as an Exhibit to this Form N-CSR.

**(b)** At a meeting held on September 12, 2024, the Audit Committee and Board of Trustees of the Trust approved the appointment of Ernst & Young LLC ("EY") as the Fund's independent registered public accounting firm for the fiscal year ending October 31, 2025. EY serves as the independent registered public accounting firm for all funds in the Trust. Accordingly, a change in the Predecessor Fund's independent registered public accounting firm was deemed to occur as of the closing of the Reorganization on March 28, 2025.

**19**

------

Item 9. Proxy Disclosures for Open-End Management Investment Companies (Unaudited)

At a special meeting of shareholders of the BNY Mellon Tax Managed Growth Fund, a series of BNY Mellon Investment Funds IV, Inc., (the "Predecessor Fund") held on January 15, 2025 (the "Shareholder Meeting"), shareholders of the Predecessor Fund approved an Agreement and Plan of Reorganization between the Predecessor Fund and the Trust, on behalf of the fund. After the close of business on March 28, 2025, the Predecessor Fund was reorganized into the fund and the fund acquired the assets and assumed the liabilities of the Predecessor Fund (the "Reorganization"). Upon completion of the Reorganization, the fund commenced operations and assumed the accounting history of the Predecessor Fund. See Note 1 in Item 7 for additional information regarding the Reorganization.

The proposal to approve the Agreement and Plan of Reorganization was the only matter submitted to shareholders at the Shareholder Meeting. Holders of 1,764,835.23 shares of stock of the Predecessor Fund, which constituted 51.79% of the outstanding shares of the Predecessor Fund eligible to vote, participated in the shareholder meeting or participated by proxy. Results of the vote are as follows:

  <u> Shares</u> <br>   <u> For </u> <u> Against </u> <u> Abstain </u> <br> To approve the Agreement and Plan of Reorganization 1,436,145.55 51,312.36 277,377.31

**20**

------

Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies (Unaudited)

Each Board member serves as a Board member of each fund within the Trust and BNY Mellon ETF Trust. The Board members are not compensated directly by the fund. The Board members are paid by the Adviser from the unitary management fees paid to the Adviser by the funds within the Trust and BNY Mellon ETF Trust, including the fund.

**21**

------

Item 11. Statement Regarding Basis for Approval of Investment Advisory Contracts (Unaudited)

N/A

**22**

------© 2025 BNY Mellon Securities Corporation

Code-4869NCSRAR1025

![](img3d497e391.gif)

------

**BNY Mellon ETF Trust II**

**ANNUAL FINANCIALS AND OTHER INFORMATION**

October 31, 2025

------

**BNY Mellon Dynamic Value ETF:** BKDV

Principal U.S. Listing Exchange: NYSE Arca, Inc.

![](imgc589e2551.gif)

------

**Save time. Save paper. View your next shareholder report online as soon as it's available. Log into** www.bny.com/investments **and sign up for eCommunications. It's simple and only takes a few minutes.**

------

The views expressed herein are current to the date of this report. These views and the composition of the

fund's portfolio is subject to change at any time based on market and other conditions.

Not FDIC-Insured • Not Bank-Guaranteed • May Lose Value

------

Contents

The Fund

Please note the Annual Financials and Other Information only contains Items 7-11 required in Form N-CSR. All other required items will be filed with the Securities and Exchange Commission (the "SEC").

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| **[Item 7. Financial Statements and Financial Highlights for Open-End Management](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_SOI-Commoncontent-5107_1)**<br> **[Investment Companies](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_SOI-Commoncontent-5107_1)**<br>| 3 |
| [Schedule of Investments](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_SOI-Commoncontent-5107_1) | 3 |
| [Statement of Assets and Liabilities](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_FS-Commoncontent-5107_1) | 6 |
| [Statement of Operations](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_FS-Commoncontent-5107_2) | 7 |
| [Statement of Changes in Net Assets](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_FS-Commoncontent-5107_3) | 8 |
| [Financial Highlights](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_FIHI-Commoncontent-5107_1) | 9 |
| [Notes to Financial Statements](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_NTF-Commoncontent-5107_1) | 10 |
| [Report of Independent Registered Public Accounting Firm](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_AUD-Commoncontent-5107_1) | 16 |
| [Important Tax Information](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_ITI-Commoncontent-5107_1) | 17 |
| **[Item 8. Changes in and Disagreements with Accountants for Open-End Management](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_CDA-Commoncontent-5107_1)**<br> **[Investment Companies](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_CDA-Commoncontent-5107_1)**<br>| 18 |
| **[Item 9. Proxy Disclosures for Open-End Management Investment Companies](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_PRXD-Commoncontent-5107_1)** | 19 |
| **[Item 10. Remuneration Paid to Directors, Officers, and Other of Open-End](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_RMNP-Commoncontent-5107_1)**<br> **[Management Investment Companies](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_RMNP-Commoncontent-5107_1)**<br>| 20 |
| **[Item 11. Statement Regarding Basis for Approval of Investment Advisory Contracts](#xx_aaf6864a-cd9a-488c-9851-c2a46407030a_AAA-Commoncontent-5107_1)** | 21 |

---

------

Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.

BNY Mellon Dynamic Value ETF

SCHEDULE OF INVESTMENTS

October 31, 2025

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 99.1%** | **Common Stocks — 99.1%** | **Common Stocks — 99.1%** |
| **Banks — 10.0%** | **Banks — 10.0%** | **Banks — 10.0%** |
| Bank of America Corp. | 319026 | 17051940 |
| Citigroup, Inc. | 108730 | 11006738 |
| First Horizon Corp. | 379712 | 8110648 |
| JPMorgan Chase & Co. | 63837 | 19860967 |
|  |  | **56030293** |
| **Capital Goods — 11.3%** | **Capital Goods — 11.3%** | **Capital Goods — 11.3%** |
| Carlisle Companies, Inc. | 8257 | 2683938 |
| Caterpillar, Inc. | 18560 | 10713946 |
| Cummins, Inc. | 9256 | 4051166 |
| Emerson Electric Co. | 26871 | 3750385 |
| Ferguson Enterprises, Inc. | 16688 | 4146968 |
| Honeywell International, Inc. | 30339 | 6108151 |
| Howmet Aerospace, Inc. | 21905 | 4511335 |
| Hubbell, Inc. | 16153 | 7591910 |
| L3Harris Technologies, Inc. | 43736 | 12644078 |
| Northrop Grumman Corp. | 11654 | 6799526 |
|  |  | **63001403** |
| **Commercial & Professional Services — .5%** | **Commercial & Professional Services — .5%** | **Commercial & Professional Services — .5%** |
| Veralto Corp. | 26783 | **2642946** |
| **Consumer Discretionary Distribution & Retail — 3.5%** | **Consumer Discretionary Distribution & Retail — 3.5%** | **Consumer Discretionary Distribution & Retail — 3.5%** |
| Amazon.com, Inc.<sup>(a)</sup> <br>| 61637 | 15052988 |
| The Home Depot, Inc. | 12049 | 4573680 |
|  |  | **19626668** |
| **Consumer Services — .5%** | **Consumer Services — .5%** | **Consumer Services — .5%** |
| Royal Caribbean Cruises Ltd. | 10201 | **2925953** |
| **Energy — 9.6%** | **Energy — 9.6%** | **Energy — 9.6%** |
| Chevron Corp. | 38596 | 6087361 |
| Diamondback Energy, Inc. | 41264 | 5908592 |
| EQT Corp. | 115969 | 6213619 |
| Exxon Mobil Corp. | 128373 | 14680737 |
| Marathon Petroleum Corp. | 56109 | 10936205 |
| Phillips 66 | 73199 | 9965312 |
|  |  | **53791826** |
| **Equity Real Estate Investment Trusts — 1.1%** | **Equity Real Estate Investment Trusts — 1.1%** | **Equity Real Estate Investment Trusts — 1.1%** |
| Weyerhaeuser Co.<sup>(b)</sup> <br>| 261914 | **6024022** |
| **Financial Services — 9.7%** | **Financial Services — 9.7%** | **Financial Services — 9.7%** |
| Berkshire Hathaway, Inc., Cl. B<sup>(a)</sup> <br>| 43221 | 20639756 |
| Capital One Financial Corp. | 41114 | 9044669 |
| Morgan Stanley | 46919 | 7694716 |
| The Charles Schwab Corp. | 29695 | 2806772 |
| The Goldman Sachs Group, Inc. | 9571 | 7555060 |
| Voya Financial, Inc. | 89266 | 6646746 |
|  |  | **54387719** |
| **Health Care Equipment & Services — 8.7%** | **Health Care Equipment & Services — 8.7%** | **Health Care Equipment & Services — 8.7%** |
| Alcon AG | 35006 | 2586593 |
| Edwards Lifesciences Corp.<sup>(a)</sup> <br>| 47571 | 3922229 |
| Elevance Health, Inc. | 11735 | 3722342 |
| Humana, Inc. | 25703 | 7150318 |

---

**3**

------

SCHEDULE OF INVESTMENTS (continued)

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 99.1% (continued)** | **Common Stocks — 99.1% (continued)** | **Common Stocks — 99.1% (continued)** |
| **Health Care Equipment & Services — 8.7% (continued)** | **Health Care Equipment & Services — 8.7% (continued)** | **Health Care Equipment & Services — 8.7% (continued)** |
| Labcorp Holdings, Inc. | 21983 | 5582803 |
| Medtronic PLC | 170762 | 15488113 |
| UnitedHealth Group, Inc. | 30436 | 10395720 |
|  |  | **48848118** |
| **Household & Personal Products — 1.1%** | **Household & Personal Products — 1.1%** | **Household & Personal Products — 1.1%** |
| The Estee Lauder Companies, Inc., Cl. A | 60932 | **5891515** |
| **Insurance — 5.8%** | **Insurance — 5.8%** | **Insurance — 5.8%** |
| American International Group, Inc. | 64910 | 5125293 |
| Aon PLC, Cl. A | 33848 | 11531337 |
| Assurant, Inc. | 74968 | 15872225 |
|  |  | **32528855** |
| **Materials — 7.8%** | **Materials — 7.8%** | **Materials — 7.8%** |
| Alcoa Corp. | 110631 | 4070114 |
| CRH PLC | 131010 | 15603291 |
| Freeport-McMoRan, Inc. | 165526 | 6902434 |
| International Paper Co. | 82698 | 3195451 |
| Newmont Corp. | 92769 | 7511506 |
| Packaging Corp. of America | 31054 | 6079131 |
| Solstice Advanced Materials, Inc.<sup>(a)</sup> <br>| 7579 | 341586 |
|  |  | **43703513** |
| **Media & Entertainment — 4.7%** | **Media & Entertainment — 4.7%** | **Media & Entertainment — 4.7%** |
| Alphabet, Inc., Cl. A<sup>(a)</sup> <br>| 34818 | 9790473 |
| Meta Platforms, Inc., Cl. A | 4336 | 2811246 |
| Omnicom Group, Inc.<sup>(c)</sup> <br>| 90165 | 6764178 |
| The Walt Disney Company | 60890 | 6857432 |
|  |  | **26223329** |
| **Pharmaceuticals, Biotechnology & Life Sciences — 8.6%** | **Pharmaceuticals, Biotechnology & Life Sciences — 8.6%** | **Pharmaceuticals, Biotechnology & Life Sciences — 8.6%** |
| Bristol-Myers Squibb Co. | 87187 | 4016705 |
| Danaher Corp. | 15270 | 3288853 |
| Gilead Sciences, Inc. | 42717 | 5117069 |
| Johnson & Johnson | 116663 | 22034141 |
| Pfizer, Inc. | 149003 | 3672924 |
| Thermo Fisher Scientific, Inc. | 17825 | 10113727 |
|  |  | **48243419** |
| **Semiconductors & Semiconductor Equipment — 3.4%** | **Semiconductors & Semiconductor Equipment — 3.4%** | **Semiconductors & Semiconductor Equipment — 3.4%** |
| Advanced Micro Devices, Inc.<sup>(a)</sup> <br>| 13225 | 3387187 |
| Applied Materials, Inc. | 40663 | 9478545 |
| Intel Corp.<sup>(a)</sup> <br>| 89920 | 3595901 |
| Micron Technology, Inc. | 12402 | 2775196 |
|  |  | **19236829** |
| **Software & Services — 3.4%** | **Software & Services — 3.4%** | **Software & Services — 3.4%** |
| Akamai Technologies, Inc.<sup>(a)</sup> <br>| 33238 | 2496174 |
| Check Point Software Technologies Ltd.<sup>(a)</sup> <br>| 12283 | 2403537 |
| Dolby Laboratories, Inc., Cl. A | 81948 | 5434791 |
| International Business Machines Corp. | 27599 | 8484209 |
|  |  | **18818711** |
| **Technology Hardware & Equipment — 4.7%** | **Technology Hardware & Equipment — 4.7%** | **Technology Hardware & Equipment — 4.7%** |
| Cisco Systems, Inc. | 252378 | 18451356 |
| TE Connectivity PLC | 30701 | 7583454 |
|  |  | **26034810** |

---

**4**

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 99.1% (continued)** | **Common Stocks — 99.1% (continued)** | **Common Stocks — 99.1% (continued)** |
| **Telecommunication Services — .7%** | **Telecommunication Services — .7%** | **Telecommunication Services — .7%** |
| AT&T, Inc. | 167414 | **4143496** |
| **Transportation — 3.3%** | **Transportation — 3.3%** | **Transportation — 3.3%** |
| CSX Corp. | 259674 | 9353458 |
| Delta Air Lines, Inc. | 99680 | 5719638 |
| FedEx Corp. | 12173 | 3089751 |
|  |  | **18162847** |
| **Utilities — .7%** | **Utilities — .7%** | **Utilities — .7%** |
| Constellation Energy Corp. | 10635 | **4009395** |
| **Total Common Stocks** <br>(cost $508,662,713)<br>|  | **554275667** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | |
|:---|:---|:---|:---|
|  | 1-Day <br>Yield (%)<br>|  |  |
| **Investment Companies — .9%** | **Investment Companies — .9%** | **Investment Companies — .9%** | **Investment Companies — .9%** |
| **Registered Investment Companies — .9%** | **Registered Investment Companies — .9%** | **Registered Investment Companies — .9%** | **Registered Investment Companies — .9%** |
| Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares<sup>(d)</sup> <br>(cost $4,766,105)<br>| 4.04 | 4766105 | **4766105** |
| **Total Investments** (cost $513,428,818) | **Total Investments** (cost $513,428,818) | **100.0%** | **559041772** |
| **Cash and Receivables (Net)** | **Cash and Receivables (Net)** | **.0%** | **9337** |
| **Net Assets**  | **Net Assets**  | **100.0%** | **559051109** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> Non-income producing security.

<sup>(b)</sup> Investment in real estate investment trust within the United States.

<sup>(c)</sup> Security, or portion thereof, on loan. At October 31, 2025, the value of the fund's securities on loan was $4,395,497 and the value of the collateral was $4,486,001, consisting of U.S. Government & Agency securities. In addition, the value of collateral may include pending sales that are also on loan. 

<sup>(d)</sup> Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's prospectus. 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Affiliated Issuers** | **Affiliated Issuers** | **Affiliated Issuers** | **Affiliated Issuers** | **Affiliated Issuers** | **Affiliated Issuers** |
| Description | Value ($) <br>11/4/2024<sup>†</sup> <br>| Purchases ($)<sup>††</sup> <br>| Sales ($) | Value ($) <br>10/31/2025<br>| Dividends/ <br>Distributions ($)<br>|
| **Registered Investment Companies - .9%** | **Registered Investment Companies - .9%** | **Registered Investment Companies - .9%** | **Registered Investment Companies - .9%** | **Registered Investment Companies - .9%** | **Registered Investment Companies - .9%** |
| Dreyfus Institutional Preferred Government Money Market <br> Fund, Institutional Shares - .9%<br>| - | 37632692 | (32866587) | 4766105 | 73865 |
| **Investment of Cash Collateral for Securities Loaned - .0%** | **Investment of Cash Collateral for Securities Loaned - .0%** | **Investment of Cash Collateral for Securities Loaned - .0%** | **Investment of Cash Collateral for Securities Loaned - .0%** | **Investment of Cash Collateral for Securities Loaned - .0%** | **Investment of Cash Collateral for Securities Loaned - .0%** |
| Dreyfus Institutional Preferred Government Money Market <br> Fund, Institutional Shares - .0%<br>| - | 17987513 | (17987513) | - | 1200<sup>†††</sup> <br>|
| **Total - .9%** | **-** | **55620205** | **(50854100)** | **4766105** | **75065** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| <sup>†</sup> <br>| Commencement of operations. |
| <sup>††</sup> <br>| Includes reinvested dividends/distributions. |
| <sup>†††</sup> <br>| Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and <br> other payments to and from borrowers of securities.<br>|

---

See notes to financial statements.

**5**

------

STATEMENT OF ASSETS AND LIABILITIES

October 31, 2025

---

| | | |
|:---|:---|:---|
|  | Cost | Value |
| **Assets ($):** |  |  |
| Investments in securities—See Schedule of Investments <br>(including securities on loan, valued at $4,395,497)—Note 2(b):<br>|  |  |
| Unaffiliated issuers | 508662713 | &nbsp;&nbsp;&nbsp;&nbsp; 554275667 |
| Affiliated issuers | 4766105 | &nbsp;&nbsp;&nbsp;&nbsp; 4766105 |
| Receivable for investment securities sold |  | &nbsp;&nbsp;&nbsp;&nbsp; 805892 |
| Dividends and securities lending income receivable |  | &nbsp;&nbsp;&nbsp;&nbsp; 261924 |
| Receivable for shares of Beneficial Interest subscribed |  | &nbsp;&nbsp;&nbsp;&nbsp; 55156 |
| Tax reclaim receivable |  | &nbsp;&nbsp;&nbsp;&nbsp; 7022 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; **560171766** |
| **Liabilities ($):** |  |  |
| Due to BNY Mellon ETF Investment Adviser, LLC—Note 3(b)  |  | &nbsp;&nbsp;&nbsp;&nbsp; 258052 |
| Payable for investment securities purchased |  | &nbsp;&nbsp;&nbsp;&nbsp; 862605 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; **1120657** |
| **Net Assets ($)** |  | &nbsp;&nbsp;&nbsp;&nbsp; **559051109** |
| **Composition of Net Assets ($):** |  |  |
| Paid-in capital |  | &nbsp;&nbsp;&nbsp;&nbsp; 515888896 |
| Total distributable earnings (loss) |  | &nbsp;&nbsp;&nbsp;&nbsp; 43162213 |
| **Net Assets ($)** |  | &nbsp;&nbsp;&nbsp;&nbsp; **559051109** |
| **Shares Outstanding** |  |  |
| Shares outstanding no par value (unlimited shares authorized) |  | &nbsp;&nbsp;&nbsp;&nbsp; 19984000 |
| **Net Asset Value Per Share ($)** |  | &nbsp;&nbsp;&nbsp;&nbsp;**27.97** |
| **Market Price Per Share ($)** |  | &nbsp;&nbsp;&nbsp;&nbsp;**28.00** |

---

See notes to financial statements.

**6**

------

STATEMENT OF OPERATIONS

Period November 4, 2024 (commencement of operations) through October 31, 2025

---

| | |
|:---|:---|
| **Investment Income ($):** |  |
| **Income:** |  |
| Cash dividends: |  |
| Unaffiliated issuers | &nbsp;&nbsp;&nbsp;&nbsp; 4216306 |
| Affiliated issuers | &nbsp;&nbsp;&nbsp;&nbsp; 73865 |
| Affiliated income net of rebates from securities lending—Note 2(b)  | &nbsp;&nbsp;&nbsp;&nbsp; 1200 |
| **Total Income** | &nbsp;&nbsp;&nbsp;&nbsp; **4291371** |
| **Expenses:** |  |
| Management fee—Note 3(a)  | &nbsp;&nbsp;&nbsp;&nbsp; 1442210 |
| **Total Expenses** | &nbsp;&nbsp;&nbsp;&nbsp; **1442210** |
| **Net Investment Income** | &nbsp;&nbsp;&nbsp;&nbsp; **2849161** |
| **Realized and Unrealized Gain (Loss) on Investments—Note 4 ($):** |  |
| Net realized gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp; (5681536)<br>|
| Net realized gain (loss) on in-kind redemptions | &nbsp;&nbsp;&nbsp;&nbsp; 1998751 |
| **Net Realized Gain (Loss)** | &nbsp;&nbsp;&nbsp;&nbsp; **(3682785)**<br>|
| Net change in unrealized appreciation (depreciation) on investments | &nbsp;&nbsp;&nbsp;&nbsp; 45612954 |
| **Net Realized and Unrealized Gain (Loss) on Investments** | &nbsp;&nbsp;&nbsp;&nbsp; **41930169** |
| **Net Increase in Net Assets Resulting from Operations** | &nbsp;&nbsp;&nbsp;&nbsp; **44779330** |

---

See notes to financial statements.

**7**

------

STATEMENT OF CHANGES IN NET ASSETS

---

| | |
|:---|:---|
|  | Period Ended October 31, 2025<sup>(a)</sup>  |
|  | Period Ended October 31, 2025<sup>(a)</sup>  |
| **Operations ($):** |  |
| Net investment income | &nbsp;&nbsp;&nbsp;&nbsp; 2849161 |
| Net realized gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp; (3682785) |
| Net change in unrealized appreciation (depreciation) on investments | &nbsp;&nbsp;&nbsp;&nbsp; 45612954 |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | &nbsp;&nbsp;&nbsp;&nbsp; **44779330** |
| **Distributions ($):** |  |
| **Distributions to shareholders** | &nbsp;&nbsp;&nbsp;&nbsp; **(36764)** |
| **Beneficial Interest Transactions ($):** |  |
| Net proceeds from shares sold | &nbsp;&nbsp;&nbsp;&nbsp; 528333177 |
| Cost of shares redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (14124634) |
| **Increase (Decrease) in Net Assets from Beneficial Interest Transactions** | &nbsp;&nbsp;&nbsp;&nbsp; **514208543** |
| **Total Increase (Decrease) in Net Assets** | &nbsp;&nbsp;&nbsp;&nbsp; **558951109** |
| **Net Assets ($):** |  |
| Beginning of Period | &nbsp;&nbsp;&nbsp;&nbsp; 100000 |
| **End of Period** | &nbsp;&nbsp;&nbsp;&nbsp; **559051109** |
| **Capital Share Transactions (Shares):** |  |
| Initial shares | &nbsp;&nbsp;&nbsp;&nbsp; 4000 |
| Shares sold | &nbsp;&nbsp;&nbsp;&nbsp; 20540000 |
| Shares redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (560000) |
| **Net Increase (Decrease) in Shares Outstanding** | &nbsp;&nbsp;&nbsp;&nbsp; **19984000** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> From November 4, 2024 (commencement of operations) to October 31, 2025.

See notes to financial statements.

**8**

------

FINANCIAL HIGHLIGHTS

The following table describes the performance for the fiscal period indicated. All information (except portfolio turnover rate) reflects financial results for a single fund share. Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period, and redemption at net asset value on the last day of the period. Net asset value total return includes adjustments in accordance with accounting principles generally accepted in the United States of America and as such, the net asset value for financial reporting purposes and the returns based upon those net asset values may differ from the net asset value and returns for shareholder transactions. Market price total return is calculated assuming an initial investment made at the market price at the beginning of the period, reinvestment of all dividends and distributions at market price during the period, and sale at the market price on the last day of the period.

---

| | |
|:---|:---|
|  | Period Ended October 31, 2025<sup>(a)</sup> <br>|
| **Per Share Data ($):** | **Per Share Data ($):** |
| Net asset value, beginning of period | &nbsp;&nbsp;&nbsp;&nbsp;25.00 |
| Investment Operations: | Investment Operations: |
| Net investment income<sup>(b)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; .31 |
| Net realized and unrealized gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp;2.73 |
| Total from Investment Operations | &nbsp;&nbsp;&nbsp;&nbsp;3.04 |
| Distributions: |  |
| Dividends from net investment income | &nbsp;&nbsp;&nbsp;&nbsp; (.07)<br>|
| Net asset value, end of period | &nbsp;&nbsp;&nbsp;&nbsp;27.97 |
| Market value, end of period | &nbsp;&nbsp;&nbsp;&nbsp;28.00 |
| **Total Return (%)** | &nbsp;&nbsp;&nbsp;&nbsp; 12.20 <br><sup>(c),(d)</sup><br>|
| **Market Price Total Return (%)** | &nbsp;&nbsp;&nbsp;&nbsp; 12.31 <br><sup>(c),(d)</sup><br>|
| **Ratios/Supplemental Data (%):** | **Ratios/Supplemental Data (%):** |
| Ratio of total expenses to average net assets<sup>(e)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; .60 <br><sup>(f)</sup><br>|
| Ratio of net investment income to average net assets<sup>(e)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 1.19 <br><sup>(f)</sup><br>|
| Portfolio Turnover Rate<sup>(g)</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 104.28 <br><sup>(d)</sup><br>|
| **Net Assets, end of period ($ x 1,000)** | &nbsp;&nbsp;&nbsp;&nbsp; 559051 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> From November 4, 2024 (commencement of operations) to October 31, 2025.

<sup>(b)</sup> Based on average shares outstanding.

<sup>(c)</sup> The net asset value total return and the market price total return is calculated from fund inception. The inception date is the first date the fund was available on NYSE Arca, Inc. 

<sup>(d)</sup> Not annualized.

<sup>(e)</sup> Amount does not include the expenses of the underlying funds.

<sup>(f)</sup> Annualized.

<sup>(g)</sup> Portfolio turnover rate does not include securities received or delivered from processing creations or redemptions.

See notes to financial statements.

**9**

------

NOTES TO FINANCIAL STATEMENTS

**NOTE 1—**

**Organization:**

BNY Mellon Dynamic Value ETF (the "fund") is a separate diversified series of BNY Mellon ETF Trust II (the "Trust"), which is registered as a Massachusetts business trust under the Investment Company Act of 1940, as amended (the "Act"), as an open-ended management investment company. The Trust operates as a series company currently consisting of two series, including the fund. The fund had no operations until November 4, 2024 (commencement of operations), other than matters relating to its organization and registration under the Act. The investment objective of the fund is to seek capital appreciation. BNY Mellon ETF Investment Adviser, LLC (the "Adviser"), a wholly-owned subsidiary of The Bank of New York Mellon Corporation ("BNY"), serves as the fund's investment adviser. Newton Investment Management North America, LLC (the "Sub-Adviser" or "NIMNA"), an indirect wholly-owned subsidiary of BNY and an affiliate of the Adviser, serves as the fund's sub-adviser. NIMNA's principal office is located at BNY Mellon Center, 201 Washington Street, Boston, Massachusetts 02108. NIMNA has entered into a sub-sub-investment advisory agreement with its affiliate, Newton Investment Management Limited ("NIM"), which enables NIM to provide certain advisory services to the Sub-Adviser for the benefit of the fund, including, but not limited to, portfolio management services. NIM is subject to the supervision of NIMNA and the Adviser. NIM is also an affiliate of the Adviser. NIM, located at 160 Queen Victoria Street, London, EC4V, 4LA, England, was formed in 1978. NIM is an indirect subsidiary of BNY. The Bank of New York Mellon, a subsidiary of BNY and an affiliate of the Adviser, serves as administrator, custodian and transfer agent with the Trust. BNY Mellon Securities Corporation (the "Distributor"), a wholly-owned subsidiary of the Adviser, is the distributor of the fund's shares.

The shares of the fund are referred to herein as "Shares" or "Fund Shares." Fund Shares are listed and traded on NYSE Arca, Inc. The market price of each Share may differ to some degree from the fund's net asset value ("NAV"). Unlike conventional mutual funds, the fund issues and redeems Shares on a continuous basis, at NAV, only in a large specified number of Shares, each called a "Creation Unit". Creation Units are issued and redeemed principally in exchange for the deposit or delivery of a basket of securities. Except when aggregated in Creation Units by Authorized Participants, the Shares are not individually redeemable securities of the fund. Individual Fund Shares may only be purchased and sold on the NYSE Arca, Inc., other national securities exchanges, electronic crossing networks and other alternative trading systems through your broker-dealer at market prices. Because Fund Shares trade at market prices rather than at NAV, Fund Shares may trade at a price greater than NAV (premium) or less than NAV (discount). When buying or selling Shares in the secondary market, you may incur costs attributable to the difference between the highest price a buyer is willing to pay to purchase Shares of the fund (bid) and the lowest price a seller is willing to accept for Shares of the fund (ask).

**NOTE 2—**

**Significant Accounting Policies:**

The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") is the exclusive reference of authoritative U.S. generally accepted accounting principles ("GAAP") recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the SEC under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund's financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The Trust enters into contracts that contain a variety of indemnifications. The fund's maximum exposure under these arrangements is unknown. The funds do not anticipate recognizing any loss related to these arrangements.

**(a) Portfolio valuation:** The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund's investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

**Level 1**—unadjusted quoted prices in active markets for identical investments.

**Level 2**—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

**10**

------

NOTES TO FINANCIAL STATEMENTS (continued)

**Level 3**—significant unobservable inputs (including the fund's own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund's investments are as follows:

The Trust's Board of Trustees (the "Board") has designated the Adviser as the fund's valuation designee to make all fair value determinations with respect to the fund's portfolio of investments, subject to the Board's oversight and pursuant to Rule 2a-5 under the Act.

Investments in equity securities, including shares of REITs and ETFs (but not including investments in other open-end registered investment companies), generally are valued at the last sales price on the day of valuation of the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Association of Securities Dealers Automated Quotation System ("NASDAQ") markets generally will be valued at the official closing price. If there are no transactions in a security, or no official closing prices for a NASDAQ market-listed security on that day, the security will be valued at the average of the most recent bid and asked prices. Bid price is used when no asked price is available. Open short positions for which there is no sale price on a given day are valued at the lowest asked price. Investments in other open-end investment companies are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to reflect fair value accurately, are valued at fair value as determined in good faith based on procedures approved by the Board. Fair value of investments may be determined by valuation designee using such information as it deems appropriate under the circumstances. The factors that may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and are generally categorized within Level 3 of the fair value hierarchy.

The following is a summary of the inputs used as of October 31, 2025 in valuing the fund's investments:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1 -** <br>**Unadjusted** <br>**Quoted Prices**<br>| **Level 2- Other** <br>**Significant** <br>**Observable Inputs**<br>| **Level 3-** <br>**Significant** <br>**Unobservable** <br>**Inputs**<br>| **Total** |
| **Assets ($)** |  |  |  |  |
| Investments in Securities:<sup>†</sup> <br>|  |  |  |  |
| Equity Securities - Common Stocks | &nbsp;&nbsp; 554275667 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **554275667** |
| Investment Companies | &nbsp;&nbsp; 4766105 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **4766105** |
|  | &nbsp;&nbsp; **559041772** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **559041772** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>†</sup> See Schedule of Investments for additional detailed categorizations, if any.

**(b) Securities transactions and investment income:** Securities transactions are recorded on a trade date basis. Realized gains and losses from securities transactions are recorded on the identified cost basis. Dividend income is recognized on the ex-dividend date and interest income, including, where applicable, accretion of discount and amortization of premium on investments, is recognized on the accrual basis.

Pursuant to a securities lending agreement with BNY, the fund may lend securities to qualified institutions. It is the fund's policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by the Adviser, or U.S. Government and Agency securities. Any non-cash collateral received cannot be sold or re-pledged by the fund, except in the event of borrower default, and is not reflected in the Statement of Assets and Liabilities. The securities on loan, if any, are also disclosed in the fund's Schedule of Investments. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to

**11**

------

NOTES TO FINANCIAL STATEMENTS (continued)

income earned as a result of the lending transaction. Should a borrower fail to return the securities in a timely manner, BNY is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund's rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis. During the period ended October 31, 2025, BNY earned $166 from the lending of the fund's portfolio securities, pursuant to the securities lending agreement.

For financial reporting purposes, the fund elects not to offset assets and liabilities subject to a securities lending agreement, if any, in the Statement of Assets and Liabilities. Therefore, all qualifying transactions are presented on a gross basis in the Statement of Assets and Liabilities. As of October 31, 2025, the fund had securities lending and the impact of netting of assets and liabilities and the offsetting of collateral pledged or received, if any, based on contractual netting/set-off provisions in the securities lending agreement are detailed in the following table:

---

| | |
|:---|:---|
| **Assets ($)** |  |
| Gross amount of securities loaned, at <br> value, as disclosed in the Statement <br>of Assets and Liabilities<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4395497 |
| Collateral (received)/posted not offset <br>in the Statement of <br>Assets and Liabilities<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4395497 )<sup>†</sup><br>|
| Net amount | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| <sup>†</sup> <br>| The value of the related collateral received by the fund exceeded the value of the securities loaned by the fund pursuant to the securities lending agreement. In addition, <br> the value of collateral may include pending sales that are also on loan. See Schedule of Investments for detailed information regarding collateral received for open <br> securities lending.<br>|

---

**(c) Affiliated issuers:** Investments in other investment companies advised by the Adviser or its affiliates are considered "affiliated" under the Act.

**(d) Market Risk:** The value of the securities in which the fund invests may be affected by political, regulatory, economic and social developments, and developments that impact specific economic sectors, industries or segments of the market. In addition, turbulence in financial markets and reduced liquidity in equity, credit and/or fixed-income markets may negatively affect many issuers, which could adversely affect the fund. Global economies and financial markets are becoming increasingly interconnected, and conditions and events in one country, region or financial market may adversely impact issuers in a different country, region or financial market. These risks may be magnified if certain events or developments adversely interrupt the global supply chain; in these and other circumstances, such risks might affect companies world-wide.

**Fluctuation of Net Asset Value, Share Premiums and Discounts Risk:** As with all exchange-traded funds, fund shares may be bought and sold in the secondary market at market prices. The trading prices of fund shares in the secondary market may differ from the fund's daily net asset value per share and there may be times when the market price of the shares is more than the net asset value per share (premium) of less than the net asset value per shares (discount). This risk is heightened in times of market volatility or periods of steep market declines.

**Authorized Participants, Market Makers and Liquidity Providers Risk:** The fund has a limited number of financial institutions that may act as Authorized Participants, which are responsible for the creation and redemption activity for the fund. In addition, there may be a limited number of market makers and/or liquidity providers in the marketplace. To the extent either of the following events occur, fund shares may trade at a material discount to net asset value and possibly face delisting: (i) Authorized Participants exit the business or otherwise become unable to process creation and/or redemption orders and no other Authorized Participants step forward to perform these services, or (ii) market makers and/or liquidity providers exit the business or significantly reduce their business activities and no other entities step forward to perform their functions.

**(e) Dividends and distributions to shareholders:** Dividends and distributions are recorded on the ex-dividend date. Dividends from net investment income and dividends from net realized capital gains, if any, are normally declared and paid annually, but the fund may make distributions on a more frequent basis to comply with the distribution requirements of the Internal Revenue Code of 1986, as amended (the "Code"). To the extent that net realized capital gains can be offset by capital loss carryovers, it is the policy of the fund not to distribute such gains. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP.

**12**

------

NOTES TO FINANCIAL STATEMENTS (continued)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**(f) Federal income taxes:** It is the policy of the fund to continue to qualify as a regulated investment company, if such qualification is in the best interests of its shareholders, by complying with the applicable provisions of the Code, and to make distributions of taxable income and net realized capital gain sufficient to relieve it from substantially all federal income and excise taxes.

As of and during the period ended October 31, 2025, the fund did not have any liabilities for any uncertain tax positions. The fund recognizes interest and penalties, if any, related to uncertain tax positions as income tax expense in the Statement of Operations. During the period ended October 31, 2025, the fund did not incur any interest or penalties.

The tax year in the period ended October 31, 2025 remains subject to examination by the Internal Revenue Service and state taxing authorities.

At October 31, 2025, the components of accumulated earnings on a tax basis were as follows: undistributed ordinary income $2,812,707, accumulated capital losses $710,810 and unrealized appreciation $41,060,316.

The fund is permitted to carry forward capital losses for an unlimited period. Furthermore, capital loss carryovers retain their character as either short-term or long-term capital losses.

The accumulated capital loss carryover is available for federal income tax purposes to be applied against future net realized capital gains, if any, realized subsequent to October 31, 2025. The fund has $710,810 of short-term capital losses which can be carried forward for an unlimited period.

The tax character of distributions paid to shareholders during the fiscal period ended October 31, 2025 were as follows: ordinary income $36,764.

During the period ended October 31, 2025, as a result of permanent book to tax differences, primarily due to in-kind transactions, the fund decreased total distributable earnings (loss) by $1,580,353 and increased paid-in capital by the same amount. Net assets and net asset value per share were not affected by this reclassification.

**(g) Operating segment reporting:** In this reporting period, the fund adopted FASB Accounting Standards Update 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures ("ASU 2023-07"). Adoption of the new standard impacted financial statement disclosures only and did not affect the fund's financial position or the results of its operations. The ASU 2023-07 is effective for public entities for fiscal years beginning after December 15, 2023, and requires retrospective application for all prior periods presented within the financial statements.

Since its commencement, the fund operates and is managed as a single reportable segment deriving returns in the form of dividends, interest and/or gains from the investments made in pursuit of its single stated investment objective as outlined in the fund's prospectus. The accounting policies of the fund are consistent with those described in these Notes to Financial Statements. The chief operating decision maker ("CODM") is represented by BNY Investments. The CODM is comprised of Senior Management and Directors of BNY Investments. The CODM considers net increase in net assets resulting from operations in deciding whether to purchase additional investments or to make distributions to fund shareholders. Detailed financial information for the fund is disclosed within these financial statements with total assets and liabilities disclosed on the Statement of Assets and Liabilities, investments held on the Schedule of Investments, results of operations and significant segment expenses on the Statement of Operations and other information about the fund's performance, including total return, portfolio turnover and ratios within the Financial Highlights.

**NOTE 3—**

**Management Fee, Sub-Advisory Fee and Other Transactions with Affiliates:**

**(a)** Pursuant to a management agreement with the Adviser, the management fee is computed at an annual rate of .60% of the value of the fund's average daily net assets and is payable monthly. The fund's management agreement provides that the Adviser pays substantially all expenses of the fund, except for the management fees, payments under the fund's 12b-1 plan (if any), interest expenses, taxes, acquired fund fees and expenses, brokerage commissions, costs of holding shareholder meetings, fees and expenses associated with the fund's securities lending program, and litigation and potential litigation and other extraordinary expenses not incurred in the ordinary course of the fund's business.

The Adviser may from time to time voluntarily waive and/or reimburse fees or expenses in order to limit total annual fund operating expenses. Any such voluntary waiver or reimbursement may be eliminated by the Adviser at any time. During the period ended October 31, 2025, there was no voluntary reduction in expenses pursuant to the undertaking.

Pursuant to a sub-investment advisory agreement between the Adviser and the Sub-Adviser, the Sub-Adviser serves as the fund's sub-adviser responsible for the day-to-day management of the fund's portfolio. The Adviser pays the Sub-Adviser a monthly fee at an annual percentage of the value of the fund's average daily net assets. The Adviser has obtained an exemptive order from the SEC (the "Order"),

**13**

------

NOTES TO FINANCIAL STATEMENTS (continued)

upon which the fund may rely, to use a manager of managers approach that permits the Adviser, subject to certain conditions and approval by the Board, to enter into and materially amend sub-investment advisory agreements with one or more sub-advisers who are either unaffiliated with the Adviser or are wholly-owned subsidiaries (as defined under the Act) of the Adviser's ultimate parent company, BNY, without obtaining shareholder approval. The Order also allows the fund to disclose the sub-advisory fee paid by the Adviser to any unaffiliated sub-adviser in the aggregate with other unaffiliated sub-advisers in documents filed with the SEC and provided to shareholders. In addition, pursuant to the Order, it is not necessary to disclose the sub-advisory fee payable by the Adviser separately to a sub-adviser that is a wholly-owned subsidiary of BNY in documents filed with the SEC and provided to shareholders; such fees are to be aggregated with fees payable to the Adviser. The Adviser has ultimate responsibility (subject to oversight by the Board) to supervise any sub-adviser and recommend the hiring, termination, and replacement of any sub-adviser to the Board.

Pursuant to a sub-investment advisory agreement between the Adviser and the Sub-Adviser, the Adviser (not the fund) pays the Sub-Adviser a monthly fee at an annual rate of .30% of the value of the fund's average daily net assets.

**(b)** The fund has an arrangement with The Bank of New York Mellon (the "Custodian"), a subsidiary of BNY and an affiliate of the Adviser, whereby the fund will receive interest income or be charged overdraft fees when cash balances are maintained. For financial reporting purposes, the fund includes this interest income and overdraft fees, if any, as interest income in the Statement of Operations.

The components of "Due to BNY Mellon ETF Investment Adviser, LLC" in the Statement of Assets and Liabilities consist of: Management fee of $258,052.

**(c)** Each Board member serves as a Board member of each fund within the Trust. The Board members are not compensated directly by the fund. The Board members are paid by the Adviser from the unitary management fees paid to the Adviser by the funds within the Trust, including the fund.

**NOTE 4—**

**Securities Transactions:**

The aggregate amount of purchases and sales of investment securities, excluding short-term securities and in-kind transactions, if any, during the period ended October 31, 2025, amounted to $273,875,943 and $268,052,893, respectively.

At October 31, 2025, the cost of investments for federal income tax purposes was $517,981,456; accordingly, accumulated net unrealized appreciation on investments was $41,060,316, consisting of $55,459,968 gross unrealized appreciation and $14,399,652 gross unrealized depreciation.

**NOTE 5—**

**Shareholder Transactions:**

The fund issues and redeems its shares on a continuous basis, at NAV, to certain institutional investors known as "Authorized Participants" (typically market makers or other broker-dealers) only in a large specified number of shares called a Creation Unit. Except when aggregated in Creation Units, shares of the fund are not redeemable. The value of the fund is determined once each business day. The Creation Unit size for the fund may change. Authorized Participants will be notified of such change. Creation Unit transactions may be made in-kind, for cash, or for a combination of securities and cash. The principal consideration for creations and redemptions for the fund is in-kind, although this may be revised at any time without notice. The Trust issues and sells shares of the fund only: in Creation Units on a continuous basis through the Distributor, without a sales load, at their NAV per share determined after receipt of an order, on any Business Day, in proper form pursuant to the terms of the Authorized Participant Agreement. Transactions in capital shares for the fund are disclosed in detail in the Statement of Changes in Net Assets. The consideration for the purchase of Creation Units of the fund may consist of the in-kind deposit of a designated portfolio of securities and a specified amount of cash. Investors purchasing and redeeming Creation Units may pay a purchase transaction fee and a redemption transaction fee directly to the Trust and/or custodian to offset transfer and other transaction costs associated with the issuance and redemption of Creation Units, including Creation Units for cash. The Adviser or its affiliates (the "Selling Shareholder") may purchase Creation Units through a broker-dealer to "seed" (in whole or in part) funds as they are launched or may purchase shares from broker-dealers or other investors that have previously provided "seed" for funds when they were launched or otherwise in secondary market transactions. Because the Selling Shareholder may be deemed an affiliate of such funds, the fund shares are being registered to permit the resale of these shares from time to time after purchase. The fund will not receive any of the proceeds from resale by the Selling Shareholders of these fund shares. An additional variable fee may be charged for certain transactions. Such variable charges, if any, are included in "Transaction fees" on the Statement of Changes in Net Assets.

**In-kind Redemptions:** For financial reporting purposes, in-kind redemptions are treated as sales of securities resulting in realized capital gains or losses to the fund. Because such gains or losses are not taxable to the fund and are not distributed to existing fund

**14**

------

NOTES TO FINANCIAL STATEMENTS (continued)

shareholders, the gains or losses are reclassified from accumulated net realized gain (loss) to paid-in capital at the end of the fund's tax year. These reclassifications have no effect on net assets or net asset value per share. During the period ended October 31, 2025, the fund had in-kind transactions associated with creations of $520,613,168 and redemptions of $14,027,810.

**15**

------

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Trustees of BNY Mellon Dynamic Value ETF

Opinion on the Financial Statements

We have audited the accompanying statement of assets and liabilities of BNY Mellon Dynamic Value ETF (the "Fund") (one of the funds constituting BNY Mellon ETF Trust II (the "Trust")), including the schedule of investments, as of October 31, 2025, and the related statements of operations, changes in net assets, and the financial highlights for the period from November 4, 2024 (commencement of operations) through October 31, 2025 and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund (one of the funds constituting BNY Mellon ETF Trust II) at October 31, 2025, the results of its operations, the changes in its net assets and its financial highlights for the period from November 4, 2024 (commencement of operations) through October 31, 2025, in conformity with U.S. generally accepted accounting principles.

Basis for Opinion

These financial statements are the responsibility of the Trust's management. Our responsibility is to express an opinion on the Fund's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Trust in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Trust is not required to have, nor were we engaged to perform, an audit of the Trust's internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Trust's internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of October 31, 2025, by correspondence with the custodian, brokers and others; when replies were not received from brokers and others, we performed other auditing procedures. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provide a reasonable basis for our opinion. ![](imga1aa0baa2.gif)

We have served as the auditor of one or more investment companies in the BNY Mellon Family of Funds since at least 1957, but we are unable to determine the specific year.

New York, New York

December 24, 2025

**16**

------

IMPORTANT TAX INFORMATION (Unaudited)

Form 1099-DIV, Form 1042-S and other year–end tax information provide shareholders with actual calendar year amounts that should be included in their tax returns. Shareholders should consult their tax advisers.

The following distribution information is being provided as required by the Internal Revenue Code or to meet a specific state's requirement.

The fund designates the following amounts or, if subsequently determined to be different, the maximum amount allowable for its fiscal period ended October 31, 2025:

For federal tax purposes the fund hereby reports 100% of ordinary income dividends paid during the fiscal period ended October 31, 2025 as qualified dividend income and corporate dividends received deduction.

**17**

------

Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies (Unaudited)

N/A

**18**

------

Item 9. Proxy Disclosures for Open-End Management Investment Companies (Unaudited)

N/A

**19**

------

Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies (Unaudited)

Each Board member serves as a Board member of each fund within the Trust and BNY Mellon ETF Trust. The Board members are not compensated directly by the fund. The Board members are paid by the Adviser from the unitary management fees paid to the Adviser by the funds within the Trust and BNY Mellon ETF Trust, including the fund.

**20**

------

Item 11. Statement Regarding Basis for Approval of Investment Advisory Contracts (Unaudited)

N/A

**21**

------© 2025 BNY Mellon Securities Corporation

Code-4866NCSRAR1025

![](imgc589e2551.gif)

------

**Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.**

Not applicable.

**Item 13. Portfolio Managers of Closed-End Management Investment Companies.**

Not applicable.

**Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.**

Not applicable.

**Item 15. Submission of Matters to a Vote of Security Holders.**

There have been no material changes to the procedures by which the shareholders may recommend nominees to the Registrant's Board of Trustees, where those changes were implemented after the Registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K (17 CFR 229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR 240.14a-101)), or this Item.

**Item 16. Controls and Procedures.**

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Registrant's principal executive and principal financial officers,
 or persons performing similar functions, have concluded that the Registrant's disclosure controls and procedures (as defined in
 Rule 30a-3(c) under the 1940 Act (17 CFR 270.30a-3(c))) are effective, as of a date within 90 days of the filing date of the report that
 includes the disclosure required by this paragraph, based on their evaluation of these controls and procedures required by Rule 30a-3(b)
 under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR
 240.13a-15(b) or 240.15d-15(b)).

&nbsp;&nbsp;&nbsp;&nbsp;(b) There were no changes in the Registrant's internal control over financial
 reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a-3(d))) that occurred during the period covered by this report
 that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.

**Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.**

Not applicable.

**Item 18. Recovery of Erroneously Awarded Compensation.**

Not Applicable.

**Item 19. Exhibits.**

(a)(1) [Code of ethics that is the subject of disclosure required by Item 2 of this Form N-CSR is attached hereto](exh19a1soxcoe_etf.htm).

(a)(2) Not applicable.

(a)(3) [Certifications pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto](exhibit302-etf.htm).

(a)(4) Not applicable.

(a)(5)(i) [Change in Registrant's Independent Public Accountant attached hereto](exhibit19a5i-achange.htm).

(a)(5)(ii) [Letter from Registrant's former Independent Public Accountant attached hereto](exhbit19a5iiacclttr-tmgf.htm).

(b) [Certifications pursuant to Rule 30a-2(b) under the 1940 Act and Section 906 of the Sarbanes-Oxley Act of 2002 are attached hereto](exhibit-906_etf.htm) .

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant) <u>BNY Mellon ETF Trust II</u> 

By (Signature and Title) \* <u>/s/ David J. DiPetrillo</u> David J. DiPetrillo, President

(Principal Executive Officer)

Date <u>12/23/2025</u> 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By (Signature and Title) \* <u>/s/ David J. DiPetrillo</u> David J. DiPetrillo, President

(Principal Executive Officer)

Date <u>12/23/2025</u> 

By (Signature and Title) \* <u>/s/ James Windels</u> James Windels, Treasurer

(Principal Financial and Accounting Officer)

Date <u>12/24/2025</u> 

 

<sup>\*</sup> Print the name and title of each signing officer under his or her signature.

## Ex-99.Code

**Sarbanes-Oxley Code of Ethics for Principal Executive, Financial and Accounting Officers**

Most Recently Revised: January 2022

![](graphicsimage_002.gif)

**Background**

In accordance with the Sarbanes-Oxley Act of 2002 (the "SOX Act") and the rules promulgated thereunder by the SEC, a RIC is required to file, on a semi-annual basis, a report on Form N-CSR in which the RIC must disclose whether it has adopted, for the purposes set forth below, a code of ethics applicable to certain of its officers.

Such a code of ethics will govern the conduct of a RIC's principal executive officer, the principal financial officer, the principal accounting officer or controller or persons performing similar functions (each a "Covered Officer" and collectively, "Covered Officers"), regardless of whether such persons are employed by the RIC or a third party for the purpose of promoting:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Honest and ethical conduct, including the ethical handling of actual or apparent
conflicts of interest between personal and professional relationships;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Full, fair, accurate, timely, and understandable disclosure in reports and documents
that a RIC files with, or submits to, the SEC and in other public communications by the RIC;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Compliance with applicable governmental laws, rules and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o The prompt internal reporting of violations of the code of ethics to the appropriate
persons as set forth in the code of ethics; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Accountability for adherence to the code of ethics.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Each Covered Officer should adhere to a high standard of business ethics and should
be sensitive to situations that may give rise to actual as well as apparent conflicts of interest. All Covered Officers must become familiar
and fully comply with the code of ethics.

**Policies and Procedures**

**<u>Conflicts of Interest</u>**

A "conflict of interest" occurs when a Covered Officer's private interest interferes with the interests of, or his or her service to, the Funds. For example, a conflict of interest would arise if a Covered Officer receives improper personal benefits as a result of his or her position with the Funds.

Certain conflicts of interest may arise out of the relationships between Covered Officers and the Funds and already are subject to conflict of interest provisions in the IC Act and the Advisers Act. For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with the Funds because of their status as "affiliated persons" of a Fund. Each Fund and certain of its Service Providers' compliance programs and procedures are designed to prevent, or identify and correct, violations of these provisions. This code of ethics does not, and is not intended to,

repeat or replace these programs and procedures, and such conflicts fall outside the parameters of this code of ethics. Rather, this code of ethics (the "SOX Code") is intended to address the Covered Officers' obligations under the SOX Act.

Although typically not presenting an opportunity for improper personal benefit, conflicts may arise from, or as a result of, the contractual relationship between the Funds and their investment adviser, principal underwriter, or administrator (each an "Employer") of which the Covered Officers may be officers or employees. As a result, this SOX Code recognizes that the Covered Officers will, in the normal course of their duties (whether for the Funds or an Employer), be involved in establishing policies and implementing decisions that will have different effects on the Employer and the Funds. The participation of the Covered Officers in such activities is inherent in the contractual relationships between the Funds and the Employers and is consistent with the performance by the Covered Officers of their duties as officers of the Funds. Thus, if performed in conformity with the provisions of the IC Act and the Advisers Act, such activities normally will be deemed to have been handled ethically. In addition, it is recognized by the Board that the Covered Officers may also be officers or employees of one or more other investment companies covered by this SOX Code or other codes of ethics.

Other conflicts of interest are covered by the SOX Code, even if such conflicts of interest are not subject to provisions in the IC Act and the Advisers Act. While it is impossible to describe all conflicts that may arise, a conflict should be considered to exist whenever a Covered Officer participates, directly or indirectly, in any material investment, interest, association, activity or relationship that a reasonable observer would view as likely to impair the Covered Officer's objectivity. Disclosure of conflicts should be made to the CCO or other appropriate senior executive or to a member of the Board. Covered Officers that are unsure whether a particular fact pattern gives rise to a conflict of interest or whether a particular transaction or relationship is "material" should bring such matter to the attention of the CCO.

**<u>Disclosure Documents and Compliance</u>**

Covered Officers must not knowingly make any misrepresentations regarding the Funds' financial statements or any facts in the preparation of the Funds' financial statements, and must comply with all applicable laws, standards, principles, guidelines, rules and regulations in the preparation of the Funds' financial statements. This section is intended to prohibit an officer from knowingly:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Making, or permitting or directing another to make, materially false or misleading entries in the Funds'
financial statements or records;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Failing to correct the Funds' financial statements or records that are materially false or misleading
when he or she has the authority to record an entry; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Signing, or permitting or directing another to sign, a document containing materially false or misleading
financial information.

Each Covered Officer:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Should familiarize himself or herself with the disclosure requirements generally applicable to the Funds;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Should not knowingly misrepresent, or cause others to misrepresent,
facts about the Funds to others, including to the Board, auditors, governmental regulators or self-regulatory organizations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Should promote full, fair, accurate, timely and understandable disclosure in the
reports and documents the Funds file with, or submit to, the SEC and in other public communications made by the Funds; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Has the responsibility to promote compliance with the standards and restrictions
imposed by applicable laws, rules and regulations.

**<u>Reporting of Violations and Sanctions</u>**

Covered Officers should promptly report any conduct or actions by themselves or another Covered Officer that do not comply or otherwise violate this SOX Code to the CCO. The CCO is charged with investigating any allegation and will report his or her findings and recommendations to the Board's Audit Committee. If the Audit Committee concludes that the Covered Officer has violated this SOX Code, it may impose appropriate sanctions, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· A reprimand;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Disgorgement of any profit or restitution of any loss;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Imposition of additional controls and procedures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Suspension;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Termination; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Any other measure that the Audit Committee may decide is appropriate under the circumstances, including
notifying regulatory authorities.

Any matter that the Audit Committee believes is a material violation will be promptly reported to the Board.

A Covered Officer must not retaliate against any other Covered Officer or any employee or agent of an affiliated person of the Funds for good faith reports of potential violations.

**<u>Accountability of Covered Officers</u>**

Each Covered Officer must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Upon adoption of the SOX Code (or thereafter as applicable, upon becoming a Covered
Officer), affirm in writing to the Board that he or she has received, read, and understands the SOX Code; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Annually thereafter affirm to the Board that he or she has complied with the requirements
of the SOX Code.

**<u>Other Policies and Procedures</u>**

This SOX Code shall be the sole code of ethics adopted by the Funds for purposes of Section 406 of the SOX Act and the rules and forms applicable to RICs thereunder. Insofar as other policies or procedures of the Funds, the Employers or other Service Providers govern or purport to govern the behavior or activities of the Covered Officers who are subject to this SOX Code, they are superseded by this SOX Code to the extent that they overlap or conflict with the provisions of this SOX Code. The Funds and any Employer code of ethics under Rule 17j-1 under the IC Act are separate requirements applying to the Covered Officers and others, and are not part of this SOX Code.

**<u>Amendments</u>**

The Board may from time to time amend this SOX Code or adopt such interpretations of this SOX Code as they deem appropriate. Any amendments to this SOX Code will be provided to the Covered Officers.

**<u>Internal Use and Confidentiality</u>**

All reports and records prepared or maintained pursuant to this SOX Code shall be treated as confidential and shall not be disclosed to anyone other than the Board, the Covered Officers and Fund Counsel, except as otherwise requested in accordance with applicable law.

The SOX Code is intended solely for the internal use by the Funds and does not constitute an admission, by or on behalf of the Funds, as to any fact, circumstance, or legal conclusion.

***Exhibit A - Certification of Compliance with Sarbanes-Oxley Code of Ethics for Principal Executive, Financial and Accounting Officers***

 ****

(OFFICER NAME), in his/her capacity as a Covered Officer under the Sarbanes-Oxley Code of Ethics for Principal Executive, Financial and Accounting Officers (the "Code") adopted by the funds in the BNY Mellon ETF Trust (the "Trust"), does hereby affirm to the Board of Trustees of the Trust that he/she has complied with the requirements of the Code during (YEAR).

Officer Name (Please Print)<u> </u>

Officer Signature<u> </u>

Date<u> </u>

## Ex-99.Cert

**Certification Pursuant to Rule 30a-2(a) under the 1940 Act and**

**Section 302 of the Sarbanes-Oxley Act of 2002**

I, David J. DiPetrillo, certify that:

1. I have reviewed this report on Form N-CSR of BNY Mellon ETF Trust II;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the
financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this
report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting
(as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to
be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing
date of this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that
occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's
internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the
audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report
financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| &nbsp;&nbsp;Date: <u>12/23/2025</u> | &nbsp;&nbsp; <u>/s/ David J. DiPetrillo</u> <br> David J. DiPetrillo, President<br> (Principal Executive Officer) |

---

**Certification Pursuant to Rule 30a-2(a) under the 1940 Act and**

**Section 302 of the Sarbanes-Oxley Act of 2002**

I, James Windels, certify that:

1. I have reviewed this report on Form N-CSR of BNY Mellon ETF Trust II;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the
financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this
report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting
(as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to
be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing
date of this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that
occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's
internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the
audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report
financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| &nbsp;&nbsp;Date: <u>12/24/2025</u> | &nbsp;&nbsp; <u>/s/ James Windels</u> <br> James Windels, Treasuer<br> (Principal Financial and Accounting Officer) |

---

## Exhibit 99.906

**Certification Pursuant to Rule 30a-2(b) under the 1940 Act and** 

**Section 906 of the Sarbanes-Oxley Act of 2002** 

Each of the undersigned hereby certifies that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Form N-CSR of BNY Mellon ETF Trust II (the "Report") fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of BNY Mellon ETF Trust II.

Date: <u>12/23/2025</u> <u>/s/ David J. DiPetrillo</u> 

David J. DiPetrillo, President

(Principal Executive Officer)

Date: <u>12/24/2025</u> <u>/s/ James Windels</u> 

James Windels, Treasurer

(Principal Financial and Accounting Officer)

## Ex-99.Ind

**Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies (Unaudited)**

(a) The Fund, which is a series of BNY Mellon ETF Trust II (the "Trust"), is the successor to the BNY Mellon Tax Managed Growth Fund, a series of BNY Mellon Investment Funds IV, Inc. (the "Predecessor Fund"). The Fund acquired the assets and assumed the liabilities of the Predecessor Fund on March 28, 2025 (the "Reorganization"). Upon completion of the Reorganization, the Fund commenced operations and assumed the accounting history of the Predecessor Fund. KPMG LLP ("KPMG") was the independent registered public accounting firm for the Predecessor Fund until the Reorganization on March 28, 2025.

During each of the two fiscal years ended October 31, 2024 and October 31, 2023, and the subsequent interim period through March 28, 2025, there were no disagreements with KPMG on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction of KPMG, would have caused KPMG to make reference to the subject matter of the disagreement in connection with KPMG's reports on the financial statements. In addition, there have been no reportable events of the kind described in Item 304(a)(1)(v) of Regulation S-K under the Securities Exchange Act of 1934 with respect to the Predecessor Fund.

The audit reports of KPMG on the financial statements of the Predecessor Fund as of and for the fiscal years ended October 31, 2024 and October 31, 2023 did not contain an adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope, or accounting principles.

The Fund provided KPMG with a copy of the foregoing disclosures and has requested that KPMG furnish the Fund with a letter addressed to the U.S. Securities and Exchange Commission (the "SEC") stating whether KPMG agrees with the above statements. A copy of the letter from KPMG is filed as an Exhibit to this Form N-CSR.

(b) At a meeting held on September 12, 2024, the Audit Committee and Board of Trustees of the Trust approved the appointment of Ernst & Young LLC ("EY") as the Fund's independent registered public accounting firm for the fiscal year ending October 31, 2025. EY serves as the independent registered public accounting firm for all funds in the BNY Mellon ETF Trust II. Accordingly, a change in the Predecessor Fund's independent registered public accounting firm was deemed to occur as of the closing of the Reorganization on March 28, 2025.

## Ex-99.Ind

![](graphicsimage_001.gif)

KPMG LLP

Two Manhattan West

375 9th Avenue, 17th Floor New York, NY 10001

December 22, 2025

Securities and Exchange Commission Washington, D.C. 20549

Ladies and Gentlemen:

We were previously principal accountants for BNY Mellon Tax Managed Growth Fund and, under the date of December 20, 2024, we reported on the financial statements of BNY Mellon Tax Managed Growth Fund as of and for the year ended October 31, 2024. On March 28, 2025, we were dismissed.

We have read the statements made by BNY Mellon Tax Managed Growth Fund included under Item 8 of Form N-CSR dated October 31, 2025, and we agree with such statements, except we are not in a position to agree or disagree with the statements in section (b) of Item 8 of Form N-CSR.

Very truly yours,

![](image_001.jpg)

KPMG LLP, a Delaware limited liability partnership and a member firm of

the KPMG global organization of independent member firms affiliated with

KPMG International Limited, a private English company limited by guarantee.